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A B S T R A C T
Background
Asthma is a chronic disease that causes reversible narrowing of the airways due to bronchoconstriction, inflammation and mucus
production. Asthma continues to be associated with significant avoidable morbidity and mortality. Self management facilitated by a
healthcare professional is important to keep symptoms controlled and to prevent exacerbations.
Telephone and Internet technologies can now be used by patients to measure lung function and asthma symptoms at home. Patients can
then share this information electronically with their healthcare provider, who can provide feedback between clinic visits. Technology
can be used in this manner to improve health outcomes and prevent the need for emergency treatment for people with asthma and
other long-term health conditions.
Objectives
To assess the efficacy and safety of home telemonitoring with healthcare professional feedback between clinic visits, compared with
usual care.
Search methods
We identified trials from the Cochrane Airways Review Group Specialised Register (CAGR) up to May 2016. We also searched
www.clinicaltrials.gov, the World Health Organization (WHO) trials portal and reference lists of other reviews, and we contacted trial
authors to ask for additional information.
Selection criteria
We included parallel randomised controlled trials (RCTs) of adults or children with asthma in which any form of technology was used
to measure and share asthma monitoring data with a healthcare provider between clinic visits, compared with other monitoring or usual
care. We excluded trials in which technologies were used for monitoring with no input from a doctor or nurse. We included studies
reported as full-text articles, those published as abstracts only and unpublished data.
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Data collection and analysis
Two review authors screened the search and independently extracted risk of bias and numerical data, resolving disagreements by
consensus.
We analysed dichotomous data as odds ratios (ORs) while using study participants as the unit of analysis, and continuous data
as mean differences (MDs) while using random-effects models. We rated evidence for all outcomes using the GRADE (Grades of
Recommendation, Assessment, Development and Evaluation Working Group) approach.
Main results
We found 18 studies including 2268 participants: 12 in adults, 5 in children and one in individuals from both age groups. Studies
generally recruited people with mild to moderate persistent asthma and followed them for between three and 12 months. People in
the intervention group were given one of a variety of technologies to record and share their symptoms (text messaging, Web systems or
phone calls), compared with a group of people who received usual care or a control intervention.
Evidence from these studies did not show clearly whether asthma telemonitoring with feedback from a healthcare professional increases
or decreases the odds of exacerbations that require a course of oral steroids (OR 0.93, 95% confidence Interval (CI) 0.60 to 1.44; 466
participants; four studies), a visit to the emergency department (OR 0.75, 95% CI 0.36 to 1.58; 1018 participants; eight studies) or a
stay in hospital (OR 0.56, 95% CI 0.21 to 1.49; 1042 participants; 10 studies) compared with usual care. Our confidence was limited
by imprecision in all three primary outcomes. Evidence quality ratings ranged from moderate to very low. None of the studies recorded
serious or non-serious adverse events separately from asthma exacerbations.
Evidence for measures of asthma control was imprecise and inconsistent, revealing possible benefit over usual care for quality of life (MD
0.23, 95% CI 0.01 to 0.45; 796 participants; six studies; I2 = 54%), but the effect was small and study results varied. Telemonitoring
interventions may provide additional benefit for two measures of lung function.
Authors’ conclusions
Current evidence does not support the widespread implementation of telemonitoring with healthcare provider feedback between asthma
clinic visits. Studies have not yet proven that additional telemonitoring strategies lead to better symptom control or reduced need for
oral steroids over usual asthma care, nor have they ruled out unintended harms. Investigators noted small benefits for quality of life,
but these are subject to risk of bias, as the studies were unblinded. Similarly, some benefits for lung function are uncertain owing to
possible attrition bias.
Larger pragmatic studies in children and adults could better determine the real-world benefits of these interventions for preventing
exacerbations and avoiding harms; it is difficult to generalise results from this review because benefits may be explained at least in
part by the increased attention participants receive by taking part in clinical trials. Qualitative studies could inform future research by
focusing on patient and provider preferences, or by identifying subgroups of patients who are more likely to attain benefit from closer
monitoring, such as those who have frequent asthma attacks.
P L A I N L A N G U A G E S U M M A R Y
What are the benefits and harms of using technology to monitor people with asthma from home?
Take-home message
A wide range of technologies have been developed to connect people with asthma to their healthcare professionals between routine
checkups. Studies that have tested these strategies have not proved that ’telemonitoring’ leads to better symptom control or fewer
attacks, and could not rule out the possibility that it may cause unintended harm by making people less likely to take action when it is
needed. Telemonitoring may have small benefits for quality of life and lung function, but these results are very uncertain.
Background
Regular contact with a doctor or an asthma nurse is important to keep on top of asthma symptoms and to change inhalers if necessary.
Telephone and Internet technologies are now used for lots of long-term health conditions as a way of monitoring symptoms between
visits to a clinic. For asthma, lung function and other asthma symptoms can be measured at home and information sent electronically
to the doctor or nurse, who can decide whether action needs to be taken before the person is due to come back to the clinic.
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Review question
We wanted to find out whether home telemonitoring including feedback from a healthcare professional offers added benefits for people
with asthma compared with their usual monitoring.
Study characteristics
We found 18 studies including a total of 2268 people: 12 included adults, five included children and one included individuals from
both age groups. Most people included in the studies had mild to moderate persistent asthma, and studies generally lasted between
three and 12 months. People in the intervention group were given one of a variety of technologies to record and share their symptoms
(text messaging, Web systems or phone calls) and were compared with a group of people who received usual care, or a control group.
Main results and quality of the evidence
We could not tell whether people in the telemonitoring groups had a higher or lower chance than people in the control group of having
attacks that would require a course of oral steroids, a visit to the emergency department or a hospital stay. No reports described other
potential harms of home telemonitoring. Studies used lots of different types of technology, and we couldn’t tell whether some were
better than others. Our confidence in the results ranged frommoderate to very low, meaning that additional studies are likely to change
some of these results and may influence how much we believe them.
Using technology to monitor people with asthma from home may offer benefits over usual care for overall quality of life, but the effect
was small, and studies did not agree with each other. These interventions may provide benefits for lung function, but lots of people
dropped out of the studies, so we couldn’t be sure.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Home telemonitoring and feedback vs usual care for people with asthma
Patient or population: people with asthma
Setting: home
Intervention: home telemonitoring with remote feedback f rom a healthcare professional
Comparison: usual monitoring
Outcomes Anticipated absolute effects* (95% CI) Relative effect
(95% CI)
Number of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Risk with usual moni-
toring
Risk with home tele-
monitoring and feed-
back
Exacerbations requir-
ing oral corticosteroids
7.3-month follow-up* *
399 per 1000 382 per 1000
(285 to 489)
OR 0.93
(0.60 to 1.44)
466
(4 RCTs)
⊕⊕©©
LOWa,b,c
2 child studies, 2 adult
studies. Subgroup dif -
ferences not signif icant
(P value = 0.78)
2 child studies and 6
adult studies in ED anal-
ysis agreed with the
OCS analysis (OR 0.75,
95% CI 0.36 to 1.58)
Exacerbations requir-
ing hospital admission
7.8-month follow-up
Children (< 16 years) OR 1.38
(0.51 to 3.68)
421
(4 RCTs)
⊕⊕⊕©
MODERATEc,d
4 child studies and 6
adult studies presented
separately owing to sig-
nif icant subgroup dif -
ferences (P value = 0.
04)
Telemonitoring benef i-
cial for adults, but prob-
ably not for children
38 per 1000 52 per 1000
(20 to 127)
Adults (17 to 65 years) OR 0.24
(0.06 to 0.94)
621
(6 RCTs)
⊕⊕⊕©
MODERATEc,d,e
83 per 1000 21 per 1000
(5 to 79)
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Asthma control
Follow-up varied f rom 3
to 12 months
Asthma control was reported in 3 dif ferent ways
across 4 studies Summary of results in Com-
ments column
- (4 RCTs) ⊕©©©
VERY LOWf,g,h
ACQi (MD -0.24, 95% CI
-0.72 to 0.24) (2 adult
studies);
ACT ’well-controlled’
(29/ 60 vs 8/ 29) (1 adult
study) (MD 0.09, 95%CI
0.92 to 1.10) (1 child
study)
Serious and non-seri-
ous adverse events
None of the studies explicit ly reported serious
or non-serious adverse events as an outcome
separate f rom asthma exacerbat ion outcomes
- (0 RCTs) N/ A No studies
Asthma- related quality
of life (AQLQ)i
9.6-month follow-up
1 to 7, higher = better
Mean AQLQ score was
3.58* * *
Mean AQLQ score in the
intervent ion group was
0.23 better (0.01 better
to 0.45 better)
- 796
(6 RCTs)
⊕⊕©©
LOWf,i
Lung function
% predicted trough
FEV1
higher = better
7.6-month follow-up
Mean predicted FEV1
was 68.4%* * *
Mean % predicted FEV1
in the intervent ion
group was 7.21%higher
(1.52 higher to 12.89
higher)
- 149
(3 RCTs)
⊕⊕⊕©
MODERATE j
-
Unscheduled health-
care visits
6.2-month follow-up
332 per 1000 329 per 1000
(155 to 565)
OR 0.99
(0.37 to 2.62)
430
(3 RCTs)
⊕©©©
VERY LOW c,k,l
Very un-
balanced dropout in 1
study showing dif ferent
ef fects f rom the other 2
(12% vs 57%)
* The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95% CI).
* * With the except ion of the asthma control outcome, where a range is given, follow-ups are given in months as a weighted mean durat ion of studies in the analysis
* * * Risk with usual monitoring was calculated as a weighted mean of scores in the control groups of studies contribut ing to the analysis. For the AQLQ analysis, this did not
include the 2 studies report ing change f rom baseline.
ACQ = Asthma Control Quest ionnaire; ACT = Asthma Control Test; AQLQ = Asthma Quality of Life Quest ionnaire; CI = conf idence interval; FEV1 = forced expiratory volume in 1
second; M D = mean dif ference; OR = odds rat io; RCT = randomised control trial; RR = risk rat io
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GRADE Working Group grades of evidence
High quality: We are very conf ident that the true ef fect lies close to that of the est imate of ef fect
M oderate quality: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of ef fect but may be substant ially dif f erent
Low quality: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of ef fect
Very low quality: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
aA couple of studies carrying < 20% of the overall weight had high attrit ion and uncertainty with select ion bias, but this was
not judged to be serious enough to downgrade (no downgrade)
bOne study could not be included because exacerbat ions were used as the unit of analysis rather than people with
exacerbat ions, and the small number of studies in the analysis compared with the emergency department and hospital
exacerbat ions analyses suggests that this may have been recorded and not reported (-1 publicat ion bias)
cConf idence intervals include important benef it of either treatment, so it is dif f icult to interpret the result (-1 imprecision)
dRisk of bias was conf ined mostly to the blinding domains, which is unlikely to have af fected this outcome. Uncertainty in the
select ion bias domains was not deemed serious enough to downgrade (no downgrade)
eHeterogeneity between studies in the adult subgroup was high but not stat ist ically signif icant, and all but one of the point
est imates lay in the same direct ion, favouring telemonitoring (no downgrade)
f Studies were generally at high risk of bias for the blinding domains, which may have af fected results on subject ive rat ing
scales (-1 risk of bias)
gSerious inconsistency between the two studies report ing the ACQ and results across asthma control outcomes did not give
a clear direct ion of ef fect (-1 inconsistency)
hImprecision varied across the 3 asthma control outcomes, but overall the ef fect was unclear owing to dif ferences in direct ion,
magnitude and conf idence intervals (-1 imprecision)
j Child and adult studies were pooled, and important heterogeneity was noted (I2 = 54%, P value = 0.06) (-1 inconsistency)
kTwo studies carrying most of the weight were judged to be at high risk of bias owing to high dropout; in part icular, Cingi
2015 had 57% dropout in the control group compared with 12% in the intervent ion group (-1 risk of bias)
lCingi showed an ef fect in the opposite direct ion to that noted in the other two studies, which introduced important
heterogeneity (I2 = 73%, P value = 0.03) (-1 inconsistency)
iThe minimal clinically important dif f erence (MCID) for both the Asthma Control Quest ionnaire (ACQ) and the Asthma Quality
of Life Quest ionnaire (AQLQ) is 0.5 units
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B A C K G R O U N D
Description of the condition
Asthma is a chronic disease of the airways that causes reversible
inflammation and narrowing of the airways, along with mucus
production (GINA 2014). These features commonly cause symp-
toms of wheezing, breathlessness, chest tightness and cough, al-
though symptoms vary between people and over time in terms of
presence, frequency and severity (GINA 2014).
Despite the emergence and updating of several national and inter-
national management guidelines recommending a range of cost-
effective treatments based on frequency and severity of symptoms
and exacerbations (e.g. BTS/SIGN 2014; GINA 2014), the dis-
ease remains a significant cause of avoidable morbidity and mor-
tality around the world (BTS/SIGN 2014; Global Asthma Report
2011; NRAD 2014). A national review of the 195 asthma deaths
that occurred between February 2012 and January 2013 in theUK
revealed that, in the year preceding their death, nearly one-third
of these individuals had no record of seeing a general practitioner
(GP), and nearly two-thirds had not had an asthma checkup in
secondary care (NRAD 2014). The importance of self monitoring
and regular checkups with a healthcare professional to monitor
symptoms and encourage adherence to preventer inhalers is now
well accepted (Gibson 2002; NRAD 2014), especially for those at
high risk of severe asthma attacks.
Description of the intervention
Information and communication technologies have been pro-
posed as a way for patients to record and share information reg-
ularly about their asthma control with a healthcare professional.
This method of monitoring may identify worsening asthma be-
tween consultations, prompting action, such as a medication
change, or an additional visit. Remote monitoring in this way is
a form of ’telehealth’, otherwise referred to as ’telecare’, ’digital
health’, ’mHealth’ or ’telemedicine’, which involves “the use of in-
formation and communication technologies to deliver healthcare
at a distance and to support patient self-management through re-
mote monitoring and personalised feedback” (Mclean 2013).
Communication technologies used in health care are varied, rang-
ing from simple automated reminder systems for patients to take
medication or attend their appointments (Gurol-Urganci 2013)
to more complex health communications sent via email (Atherton
2012), telephone systems (Cash-Gibson 2012) or text messages
(de Jongh 2012); however, feedback and personalised care from
a healthcare professional are important components of what can
be considered telehealth. Health services around the world are
considering communication technologies in their various forms as
a way of managing the rising number of people with long-term
health conditions, to improve health outcomes and reduce the
burden on emergency and inpatient services (Steventon 2012; UK
Department of Health 2012).
Governments and healthcare providers are increasingly adopting
’telehealth’ and investing in research to pin down how and for
whom it could be beneficial. Programmes include an initiative
in the UK encouraging wide availability of ’e-consultations’ and
home ’telemonitoring’ (UKDepartment of Health 2013). A Tele-
health Pilots Programme in Australia (Australian Government
Department of Health 2016) offers widespread eHealth to chron-
ically ill people and vulnerable elderly people in the Netherlands
(Government of the Netherlands 2016), along with recognition
of ’telehealth’ monitoring by US Medicaid insurance (Medicaid
2016). Studies have assessed the role of a range of technology-
based consultations and monitoring in asthma and other health
conditions, including telephone calls, email contacts, text messag-
ing and video conferencing (Laver 2013; McLean 2010; McLean
2011).
Remote monitoring of asthma with technologies might include
features such as recording symptoms online or automatically trans-
ferring home peak flow readings to a doctor or nurse. Regular
recording and remote sharing of this information may trigger a
response from a healthcare professional, who uses the information
to provide personalised care. Researchers have assessed telehealth
in several ways, including as an alternative for usual primary or
secondary care clinic appointments (e.g. Rasmussen 2005); this
was recently addressed by a related Cochrane review (Kew 2016).
However, this review will consider evidence for home telemoni-
toring of asthma control between visits with personalised feedback
from a healthcare professional (e.g. Ryan 2012).
How the intervention might work
In the context of asthma, a condition affecting more than 300
million people worldwide (Global Asthma Report 2011), which
places a significant burden on healthcare systems, telehealth may
represent an unobtrusive and efficient way of maintaining contact
between patients and healthcare professionals. Regular monitor-
ing with communication technologies may serve to enhance self
management behaviours that have known benefits for morbidity
and mortality, such as keeping personalised action plans up-to-
date and adhering tomaintenance medications (NRAD 2014). As
an alternative to methods of monitoring that do not include feed-
back from a healthcare professional, telehealth may offer a more
interactive method of supporting self management.
Although governments and health services have highlighted the
potential for cost-savings and improved clinical outcomes of tele-
health used in this way, its use to monitor patients with potentially
serious or life-threatening conditions may not be without hazard.
Focus groups have suggested that technology may be acceptable
to patients and clinicians, but they have raised concerns that it
could actually discourage self management, or might increase the
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likelihood of serious outcomes by instilling a false sense of security
(Pinnock 2007a).
The feasibility of home telemonitoring using technology in differ-
ent situations and populations may be hampered by barriers, in-
cluding insufficient healthcare infrastructure and funding (Lustig
2012). However, this approach may reduce inequality in health
care related to socioeconomic status and rural living by improving
access to services (Jannett 2003; Lustig 2012).
Why it is important to do this review
The release of the UKNational Health Service (NHS) mandate in
2013 has resulted in a push to advance the use of communication
technologies for economic and clinical benefit. A recent overview
of systematic reviews suggested that these benefits should not be
assumed, and that people at highest risk of serious health outcomes
are likely to show the biggest gains (Mclean 2013). For asthma,
existing reviews have noted a large degree of variation in the way
telehealth is delivered in studies and to whom and with what it
is compared (Jaana 2009; McLean 2010), and have been limited
for this reason in the conclusions that could be drawn. This re-
view considers evidence for ongoing personalised feedback from a
healthcare professional using home telemonitoring between visits,
compared with monitoring without feedback. A related review has
considered evidence for remote checkups as an alternative to face-
to-face asthma consultations (Kew 2016).
O B J E C T I V E S
To assess the efficacy and safety of home telemonitoring with
healthcare professional feedback between clinic visits, compared
with usual care.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included parallel randomised controlled trials (RCTs) of any
duration. We included studies reported as full-text articles, those
published as abstracts only and unpublished data.
Types of participants
We included studies of adults or children with a diagnosis of
asthma. We excluded studies recruiting participants with other
long-term health conditions, unless investigators presented data
for people with asthma separately.
Types of interventions
We included studies comparing home telemonitoring of asthma
between clinic visits, using any form of technology (e.g. telephone
calls, emails, text messages, online software), with a form of mon-
itoring that does not include ongoing remote professional feed-
back. We included studies that compared the two types of mon-
itoring on top of education or another co-intervention. We ex-
cluded studies using automated telehealth interventions that did
not include personalised input from a healthcare professional.
Types of outcome measures
Primary outcomes
1. Exacerbations requiring oral corticosteroids*.
2. Asthma control (measured on a validated scale, e.g. the
Asthma Control Questionnaire).
3. Serious adverse events (including mortality).
Secondary outcomes
1. Asthma-related quality of life (measured on a validated
scale, e.g. the Asthma Quality of Life Questionnaire (AQLQ)).
2. Unscheduled healthcare visits.
3. Lung function (trough forced expiratory volume in one
second (FEV1) preferred).
4. Adverse events/side effects.
Reporting in the study of one of more of the outcomes listed here
was not an inclusion criterion for the review.
*If studies reported exacerbations in a different way (e.g. requiring
an emergency department (ED) visit), we analysed these separately.
Search methods for identification of studies
Electronic searches
We identified trials from the Cochrane Airways Group Specialised
Register (CAGR), which is maintained by the Information Spe-
cialist for the Group. This Register contains trial reports identified
through systematic searches of bibliographic databases, including
the Cochrane Central Register of Controlled Trials (CENTRAL),
MEDLINE, EMBASE, the Cumulative Index to Nursing and Al-
lied Health Literature (CINAHL), the Allied and Complemen-
tary Medicine Database (AMED) and PsycINFO, and by hand-
searching of respiratory journals and meeting abstracts (please see
Appendix 1 for further details). We searched all records in the
CAGR using the search strategy presented in Appendix 2.
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We also conducted a search of
ClinicalTrials.gov (www.ClinicalTrials.gov) and theWorld Health
Organization (WHO) trials portal (www.who.int/ictrp/en/). We
searched all databases from their inception to May 2016, and we
imposed no restriction on language of publication.
Searching other resources
We checked the reference lists of all primary studies and review
articles for additional references. We searched relevant manufac-
turers’ websites for trial information.
On 2 August 2016, we searched for errata or retractions
from included studies published in full text on PubMed (
www.ncbi.nlm.nih.gov/pubmed).
Data collection and analysis
Selection of studies
Two review authors (KMK and CJC) independently screened ti-
tles and abstracts for inclusion of all potential studies identified as
a result of the search and coded them as ’retrieve’ (eligible or po-
tentially eligible/unclear) or ’do not retrieve’.We retrieved the full-
text study reports/publications, and two review authors (KMKand
CJC) independently screened these documents, identified studies
for inclusion and identified and recorded reasons for exclusion of
ineligible studies. We resolved disagreements through discussion.
We identified and excluded duplicates and collated multiple re-
ports of the same study, so that each study, rather than each re-
port, was the unit of interest in the review. We recorded the selec-
tion process in sufficient detail to complete a PRISMA (Preferred
Reporting Items for Systematic Reviews and Meta-Analyses) flow
diagram (Figure 1) and a Characteristics of excluded studies table
(Moher 2009).
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Figure 1. Study flow diagram.
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Data extraction and management
We used a data collection form for study characteristics and out-
come data that had been piloted on at least one study in the review.
One review author (KMK) extracted the following study charac-
teristics from the included studies.
1. Methods: study design, total duration of study, details of
any ’run-in’ period, number of study centres and locations, study
setting, withdrawals and date of study.
2. Participants: N, mean age, age range, gender, severity of
condition, diagnostic criteria, baseline lung function, smoking
history, inclusion criteria and exclusion criteria.
3. Interventions: intervention, comparison, concomitant
medications and excluded medications.
4. Outcomes: primary and secondary outcomes specified and
collected and time points reported.
5. Notes: funding for trial and notable conflicts of interest of
trial authors.
Two review authors (KMK and CJC) independently extracted
outcome data from the included studies. We noted in the
Characteristics of included studies table if outcome data were not
reported in a useable way. We resolved disagreements by consen-
sus. One review author (KMK) transferred data into the Review
Manager 5 (RevMan 2014) file.We double-checked that datawere
entered correctly by comparing data presented in the systematic
reviewwith data provided in the study reports. A second review au-
thor (CJC) spot-checked study characteristics for accuracy against
the trial report.
Assessment of risk of bias in included studies
Two review authors (KMK and CJC) independently assessed risk
of bias for each study using the criteria outlined in the Cochrane
Handbook for Systematic Reviews of Interventions (Higgins 2011).
We resolved disagreements by discussion and assessed risk of bias
according to the following domains.
1. Random sequence generation.
2. Allocation concealment.
3. Blinding of participants and personnel.
4. Blinding of outcome assessment.
5. Incomplete outcome data.
6. Selective outcome reporting.
7. Other bias.
We graded each potential source of bias as high, low or unclear,
and we provided a quote from the study report together with a
justification for our judgement in the ’Risk of bias’ table. We sum-
marised risk of bias judgements across different studies for each
of the domains listed. We considered blinding separately for dif-
ferent key outcomes when necessary (e.g. for unblinded outcome
assessment, risk of bias for all-cause mortality may be very differ-
ent than for a patient-reported pain scale). When information on
risk of bias relates to unpublished data or correspondence with a
trialist, we noted this in the ’Risk of bias’ table.
When considering treatment effects, we took into account the risk
of bias for studies that contributed to those outcomes.
Assessment of bias in conducting the systematic
review
We conducted the review according to the published protocol and
reported deviations from it in the Differences between protocol
and review section of the systematic review.
Measures of treatment effect
We analysed dichotomous data as odds ratios (ORs), and contin-
uous data as mean differences (MDs) or standardised mean differ-
ences (SMDs). We entered data presented as a scale with a consis-
tent direction of effect.
We undertook meta-analyses only when this was meaningful, i.e.
when treatments, participants and the underlying clinical question
were similar enough for pooling to make sense.
We did not include in the meta-analyses skewed data that were
reported as medians and interquartile ranges, but described the
results narratively instead.
When a single trial reported multiple trial arms, we included only
the relevant arms. When two comparisons (e.g. drug A vs placebo,
drug B vs placebo) were combined in the same meta-analysis, we
halved the control group to avoid double-counting.
Unit of analysis issues
For dichotomous outcomes, we used participants, rather than
events, as the unit of analysis (i.e. number of adults admitted to
hospital, rather than number of admissions per adult). However,
if exacerbations were reported as rate ratios, we analysed them on
this basis.
Dealing with missing data
We contacted investigators or study sponsors to verify key study
characteristics and to obtain missing numerical outcome data
when possible (e.g. when a study was identified as abstract only).
When this was not possible, and missing data were thought to
introduce serious bias, we explored the impact of including such
studies in the overall assessment of results by performing a sensi-
tivity analysis.
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Assessment of heterogeneity
We used the I² statistic to measure heterogeneity among the stud-
ies in each analysis. If we identified substantial heterogeneity, we
reported it and explored possible causes through prespecified sub-
group analysis.
Assessment of reporting biases
When we were able to pool more than 10 studies, we created
and examined a funnel plot to explore possible small-study and
publication biases.
Data synthesis
We used a random-effects model for all analyses, as we expected
variation in effects due to differences among study populations
and interventions. We performed sensitivity analyses by using a
fixed-effect model.
’Summary of findings’ table
We created a ’Summary of findings’ table by using the seven out-
comes specified above. We used the five GRADE considerations
(study limitations, consistency of effect, imprecision, indirectness
and publication bias) to assess the quality of a body of evidence as
it relates to the studies that contributed data to the meta-analyses
for prespecified outcomes. We followed methods and recommen-
dations described in Section 8.5 and Chapter 12 of the Cochrane
Handbook for Systematic Reviews of Interventions (Higgins 2011)
while using GRADEpro GDT 2015 software. We justified all de-
cisions to downgrade or upgrade the quality of studies by using
footnotes, and we made comments to aid the reader’s understand-
ing of the review, when necessary.
Subgroup analysis and investigation of heterogeneity
We planned the following subgroup analyses for the primary out-
comes, provided at least one studywas included for each subgroup.
1. Mean age (≤ 16 years, 17 to 65 years, > 65 years).
2. Type of technology (telephone calls, text messages, emails).
We used the formal test for subgroup interactions provided in
Review Manager 5 (RevMan 2014).
Sensitivity analysis
We planned to carry out sensitivity analyses, while excluding the
following from the primary analyses.
1. Studies recruiting people with severe or life-threatening
asthma.
2. Unpublished data (obtained from trial authors or from
conference abstracts).
3. Studies at high risk of detection bias*.
*Inadequate selection procedures may result in unbalanced base-
line characteristics between groups, which could skew the data. In
light of the nature of the studies, we anticipated that all or most
studies would be at high risk of performance or detection bias,
so we have discussed the possible effects of lack of blinding, in
particular for subjective outcomes.
R E S U L T S
Description of studies
Results of the search
We identified 619 records in the main electronic database search.
We identified a total of 750 additional records through a search
conducted for an older teleheathcare review with a broader scope
(McLean 2010) (n = 709), clinicaltrials.gov (n = 29) and theWorld
Health Organization (WHO) trials portal (n = 11), as well as ref-
erence lists of other reviews (n = 1). Collating all searches revealed
a total of 1369 records, of which 518 were duplicates. We screened
the remaining 851 unique records and excluded 685 by looking
at titles and abstracts alone. We reviewed full-text articles for the
remaining 166 records; 123 records related to 84 studies did not
meet the inclusion criteria and were excluded (with reasons), three
records related to two ongoing studies (Ahmed 2011; Perry 2015)
and one record is awaiting classification (Ricci 2001). This left
18 studies, with 40 associated reports, which met the inclusion
criteria for this review (see trial flow in Figure 1).
Included studies
Eighteen studies, including a total of 2268 participants, met the
inclusion criteria for this review (Bateman 2000; Cingi 2015;
Deschildre 2012; Donald 2008; Finkelstein 2005; Guendelman
2002; Jan 2007; Kokubu 1999; Kokubu 2000; Liu 2011; Ostojic
2005; Prabhakaran 2009; Ryan 2012; van der Meer 2009;
Voorend-vanBergen 2015;Willems 2008;Xu 2010; Young 2012).
An overview of study, participant and intervention characteristics
is given in Table 1, and more in-depth information and risk of
bias details can be found in the Characteristics of included studies
table.
All included studies were parallel RCTs. The number of partici-
pants in each study ranged from 16 to 288, and the median num-
ber was 120. As shown in Table 1, seven studies took place in
Europe (the Netherlands, Croatia, France, Turkey and the UK),
five in Asia (Japan, Singapore and Taiwan), three in the USA,
two in Australia and one in South Africa. Eleven studies were run
from respiratory clinics in hospitals or outpatient centres (Cingi
2015; Deschildre 2012; Donald 2008; Guendelman 2002; Jan
2007; Kokubu 2000; Liu 2011; Ostojic 2005; Prabhakaran 2009;
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Willems 2008; Xu 2010), and four from general practitioners’
offices or medical centres (Bateman 2000; Kokubu 1999; Ryan
2012; van der Meer 2009). Young 2012 was run through pharma-
cies in an 11-county region in the USA, and two studies that were
reported only as conference abstracts did not reveal the setting
in which they took place (Finkelstein 2005; Voorend-van Bergen
2015).
Population characteristics and inclusion criteria
Twelve studies recruited adults or adults and adolescents (Bateman
2000; Cingi 2015;Donald 2008; Finkelstein 2005; Kokubu 1999;
Kokubu 2000; Liu 2011; Ostojic 2005; Prabhakaran 2009; Ryan
2012; van der Meer 2009; Young 2012), five studies recruited
only children (Deschildre 2012; Guendelman 2002; Jan 2007;
Voorend-van Bergen 2015; Xu 2010) and one study recruited
both adults and children (Willems 2008). Two of the adult studies
also recruiting adolescents over 12 (Ostojic 2005; Ryan 2012)
and the one study recruiting both adults and children (Willems
2008) were classified as adult studies because the mean age of
participants was over 18, and data for children were not reported
separately. The overall weightedmean of population ages was 31.6
years (range, seven to 52.8). The mean age of child populations
was 10.4 years (range, seven to 12.1) and the mean age in adult
studies was 41.6 (range, 24.7 to 52.8). The mean percentage male
indicated a relatively even split of males and females (45.6%male),
although the percentage male in individual studies ranged from
23.5% to 74.0%.
Deschildre 2012, Kokubu 1999, Kokubu 2000 and Prabhakaran
2009 listed inclusion criteria that would have led to recruitment
of people with severe asthma; all required that participants had at
least a course of oral steroids, a visit to the ED or admission to
hospital within the previous year, and these studies excluded par-
ticipants with mild or intermittent asthma or specifically required
them tomeet the criteria for severe asthma.Otherwise, studies gen-
erally recruited people with mild to moderate persistent asthma,
and common inclusion criteria included physician-diagnosed or
guideline-diagnosed asthma, a recent prescription for asthma con-
troller medications - usually inhaled corticosteroid (ICS) or long-
acting beta agonist (LABA) + ICS - access to and competency
with relevant technologies and proficiency in the given language
(usually English). Common exclusion criteria were pregnancy or
breastfeeding, other chronic illnesses and current smoking. Two
child studies (Deschildre 2012 and Voorend-van Bergen 2015)
specifically recruited children with allergic asthma, and Ryan 2012
required that participants score 1.5 or lower on the Asthma Con-
trol Questionnaire to indicate insufficient symptom control.
Interventions and comparisons
Six trials provided three- or four-month interventions, five tri-
als gave six-month interventions and seven trials tested the in-
terventions for a year (see Table 1). All monitoring interven-
tions involved ways for participants or their parents to track their
asthma control at home and to share this information with a
healthcare professional to receive management advice between
usual clinic visits. Nine studies used an Internet-based device,
programme or website for participants to record and transmit a
range of symptom,medication or lung function data to the health-
care professional (Bateman 2000; Deschildre 2012; Finkelstein
2005;Guendelman2002; Jan2007;Kokubu 1999;Kokubu 2000;
Voorend-van Bergen 2015; Willems 2008). Healthcare profes-
sionals, often a specialist nurse, regularly reviewed the data and
responded with management advice, often based on personalised
asthma action plans. Six studies used a similar system of recording
and response that was done primarily via short message service
(SMS) or mobile phone software (Cingi 2015; Liu 2011; Ostojic
2005; Prabhakaran 2009; Ryan 2012; van der Meer 2009). Three
studies involved regular calls or email contact with a nurse or phar-
macist to monitor symptoms and advise on changes to medication
(Donald 2008; Xu 2010; Young 2012).
Most included trials used usual care as their comparison group
(Bateman 2000; Cingi 2015; Deschildre 2012; Donald 2008;
Finkelstein 2005; Jan 2007; Kokubu 1999; Kokubu 2000;
Prabhakaran 2009; Voorend-van Bergen 2015; Willems 2008; Xu
2010; Young 2012). In three of these studies, people in the usual
care group received a minimal intervention such as an education
session, a personalised asthma action plan or a peak flow meter
to encourage self monitoring at home (Donald 2008; Jan 2007;
Xu 2010). Five studies gave participants in the control group an
asthma diary or a peak flow meter to record their symptoms at
home (Guendelman 2002; Liu 2011; Ostojic 2005; Ryan 2012;
van der Meer 2009), but these data were not shared with a health-
care professional between usual visits.
Excluded studies
After reviewing the full texts, a total of 126 citations (86 studies)
were not included in the review. Itwas oftendifficult to tell whether
a study met the inclusion criteria for the review by reading the
title and abstract alone, so we excluded 122 citations (83 studies)
after viewing full texts.We classified three citations (two studies) as
ongoing (Ahmed 2011; Perry 2015), and one citation as awaiting
classification because we did not have enough details to confirm
whether it met the review’s inclusion criteria (Ricci 2001).
Of the 122 citations (83 studies) that were listed as excluded
because they did not meet the inclusion criteria, we excluded
29 (23 studies) because closer inspection showed that inves-
tigators were assessing an intervention other than home tele-
monitoring, including psychological or parenting interventions
(Aaron 2016; Chandler 1990; Chen 2013; Cicutto 2009; Clark
2007; Clarke 2014; Eakin 2012; Gustafson 2012; Halterman
2012; Huang 2013; Janevic 2012; Jerant 2003; Khan 2003;
Kojima 2005; Lobach 2013; McCowan 2001; NCT01117805;
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Osman 1997; van den Berg 2002; van Gaalen 2012; van Reisen
2010; Wiecha 2007; Zachgo 2002). We excluded 25 citations
(six studies) because researchers assessed the feasibility of replac-
ing face-to-face reviews with reviews conducted using technol-
ogy, which was a different question from the one we set out
to answer in this review (Chan 2007; Gruffydd-Jones 2005;
Hashimoto 2011; Pinnock 2003; Pinnock 2007; Rasmussen
2005). We excluded 17 citations (14 studies) because investiga-
tors were assessing the use of information technologies to deliver
asthma education (Barbanel 2003; Burbank 2012; De Vera 2014;
Dwinger 2013;Garbutt 2010;McPherson 2006;NCT00562081;
NCT00910585; NCT00964301; Pedram 2012; Peruccio 2005;
Seid 2012; Shanovich 2009; Yun 2013), 19 citations (11 stud-
ies) because researchers assessed automated feedback interventions
that did not include ongoing input from a healthcare professional
(Andersen 2007; Bender 2010; Kattan 2006; Merchant 2016;
Morrison 2014; Petrie 2012; Rikkers-Mutsaerts 2012; Searing
2012; Vasbinder 2013; Vollmer 2006; Zairina 2015), nine ci-
tations (seven studies) because investigators were reporting val-
idation of a technology-delivered asthma questionnaire (Bender
2001; Bender 2007; Price 2007; Rand 2005; Rosenzweig 2008;
Schatz 2010; Uysal 2013) and seven citations (seven studies) be-
cause the intervention was aimed purely at improving adherence
rather than monitoring asthma control (Boyd 2014; Burkhart
2002; Bynum 2001; Chatkin 2006; Foster 2014; MacDonell
2015; Taitel 2014). Ten citations (nine studies) were not reports
of RCTs and were recorded as using the wrong design for the re-
view (Apter 2000; Araujo 2012; Claus 2004; Cruz-Correia 2007;
Fonseca 2006; Friedman 1999; Lam 2011; Murphy 2001; Raat
2007), and six citations (six studies) compared a home telemoni-
toring intervention with another active comparator that was not
eligible for this review (Apter 2015; Baptist 2013; de Jongste 2008;
NCT00149474; Schatz 2003; Sparrow 2005).
Risk of bias in included studies
Figure 2 presents an overview of risk of bias in the included stud-
ies, and we provide below a summary of possible bias related to
each domain. We have given full details of the rationale for each
judgement in each study’s risk of bias table (see the Characteristics
of included studies tables).
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Figure 2. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Allocation
Much uncertainty surrounded the two selection bias domains,
despite efforts to clarify procedures with study authors. Seven
studies were at low risk of bias for random sequence generation
(Cingi 2015; Ostojic 2005; Prabhakaran 2009; Ryan 2012; van
der Meer 2009; Voorend-van Bergen 2015; Willems 2008), and
eight were at low risk for allocation concealment (Cingi 2015;
Guendelman 2002; Jan 2007; Kokubu 1999; Kokubu 2000; Ryan
2012; Voorend-van Bergen 2015; Young 2012); we considered
only Cingi 2015, Ryan 2012 and Voorend-van Bergen 2015 to be
at low risk in both selection bias domains. We rated the remaining
studies as unclear.
Blinding
It was not possible to blind participants and personnel to group
allocation because of the nature of the interventions and compar-
isons, and this posed the most serious risk of bias for the evidence
in this review. We assessed risk of performance bias separately for
objective (e.g. exacerbations) and subjective (e.g. quality of life)
outcomes to better represent how this bias was likely to have af-
fected our confidence in the results. We considered all studies to
be at low risk of performance bias for objective outcomes and at
high risk of bias for subjective outcomes.
Although theoretically outcome assessors could have been inde-
pendent from the study and blinded to allocation, we did not as-
sume that this was the case unless it was explicitly described in
the report, or unless study authors confirmed this through per-
sonal communication. Fifteen studies did not describe methods to
blind outcome assessors and did not confirm that those measuring
outcomes were not blinded to group allocation; we rated these as
having high risk of bias (Bateman 2000; Cingi 2015; Deschildre
2012; Finkelstein 2005; Guendelman 2002; Jan 2007; Kokubu
1999; Kokubu 2000; Liu 2011; Ostojic 2005; Prabhakaran 2009;
van der Meer 2009; Voorend-van Bergen 2015; Willems 2008;
Xu 2010). We rated the remaining three studies as having low risk
of bias (Donald 2008; Ryan 2012; Young 2012). Researchers de-
scribed Cingi 2015 as a double-blind trial, but participants, who
self rated their symptoms for the primary outcome, could have
conceivably worked out which group they were in by noting what
they received during the study.
Incomplete outcome data
We considered half of the included studies to be at low risk of
attrition bias because attrition was low and balanced across inter-
vention and control groups, or because we believed that meth-
ods used to replace data for participants who did not complete
the study would have adequately controlled for bias (Guendelman
2002; Jan 2007; Kokubu 2000; Ostojic 2005; Prabhakaran 2009;
Ryan 2012; Voorend-van Bergen 2015; Xu 2010; Young 2012).
We rated three studies as unclear because we could not tell how
many people dropped out of the study. We considered six studies
to be at high risk of bias, mostly because attrition was high or was
much higher in one group than in another, or because analyses did
not include those who dropped out before the end of the study.
Willems 2008 reported that up to 28% of data for particular out-
comes weremissing owing to errors with data transmission or poor
compliance with questionnaires, and Cingi 2015 analysed only
data for participants who completed the questionnaire at the end
of the study, which represented a much smaller proportion of the
control group than the intervention group (42.6% and 88.2%,
respectively).
Selective reporting
We rated 14 studies as having low risk of bias because we were
satisfied that all planned outcomes had been fully reported in pub-
lished reports, or because study authors provided us with addi-
tional information upon request. We rated Cingi 2015 as low risk,
althoughwe could notmeta-analyse some outcomes because of the
way they were reported, and statistical methods used were appro-
priate for the study data. We were unsure of the risk of reporting
bias in Kokubu 1999 because it was available only in Japanese, and
it was difficult to confirm whether all intended outcomes had been
reported, even with translation. For Kokubu 2000, the translation
confirmed that not all named outcomes had been reported suffi-
ciently to include them in meta-analyses, so we rated this study
as having high risk of bias. We rated two other studies (Bateman
2000 and Finkelstein 2005) as having high risk of bias because they
were available only as conference abstracts, not in peer-reviewed
journals, and this meant that study authors provided very little
information about the conduct of the studies or their numerical
results.
Other potential sources of bias
We did not note any additional sources of bias, so we rated all
studies as having low risk for ’other sources of bias’.
Effects of interventions
See: Summary of findings for the main comparison Summary
of findings table 1
Primary outcomes
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Exacerbations requiring oral corticosteroids
Home telemonitoring with feedback might be better or worse
than usual monitoring (odds ratio (OR) 0.93, 95% confidence
Interval (CI) 0.60 to 1.44; 466 participants; four studies; I2 = 0%;
Analysis 1.1). Over seven months, 399 people per thousand who
were monitored in their usual way had an exacerbation compared
with 382 per thousand if they received telemonitoringwith remote
feedback from a healthcare professional (95% CI 285 to 489 per
1000). We had low confidence in the estimate because only four
studies could be included in the analysis (Deschildre 2012;Donald
2008; Ryan 2012; Xu 2010), indicating possible publication bias.
In addition, confidence intervals were too wide to reveal whether
one monitoring strategy is likely to be better than another.
In addition to the four studies that were meta-analysed, Voorend-
van Bergen 2015 reported the total number of exacerbations rather
than the number of participants having at least one exacerbation,
so we could not combine their data with data from other studies.
Researchers observed 10 exacerbations among the 90 participants
in the Web group and 17 exacerbations in the 87 participants
receiving standard care.
Eight studies reported exacerbations that required a visit to the
ED (Donald 2008; Guendelman 2002; Kokubu 2000; Liu 2011;
Ryan 2012; van der Meer 2009; Willems 2008; Xu 2010), which
supported the main analysis that home telemonitoring and feed-
back might be better or worse than control (OR 0.75, 95% CI
0.36 to 1.58; 1018 participants; eight studies; I2 = 47%; Analysis
1.2).We noted important heterogeneity in the ED overall analysis
and within each child and adult subgroup. We had low confidence
in the effect because confidence intervals were too wide to show
whether one strategy is likely to be better than another, and be-
cause we noted important heterogeneity both within and across
subgroups.
A look at exacerbations requiring hospital admission revealed that
the overall pooled effect including child and adult studies showed
uncertainty in relation to benefit or harm compared with usual
monitoring (OR 0.56, 95% CI 0.21 to 1.49; 1042 participants;
10 studies; I2 = 45%; Analysis 1.3). However, the test for subgroup
differences was statistically significant, suggesting possible benefit
for adults in reducing the number of exacerbations requiring hos-
pital admission (OR 0.24, 95% CI 0.06 to 0.94).
Asthma control
Most studies did not use validated measures of asthma control,
and the four that did could not be pooled in a single analysis
(Cingi 2015; Ryan 2012; van derMeer 2009; Voorend-vanBergen
2015). Two adult studies (Ryan 2012; van der Meer 2009) used
the Asthma Control Questionnaire (ACQ), for which the mini-
mal clinically important difference (MCID) is 0.5. These studies
showed very different effects, which made the pooled result diffi-
cult to interpret (mean difference (MD) -0.24, 95% CI -0.72 to
0.24; 478 participants; two studies; I2 = 91%).
One child study (Voorend-van Bergen 2015) using the Asthma
Control Test (ACT) as a continuous variable found no difference
in scores between the two types of monitoring (MD 0.09, 95%CI
-0.92 to 1.10). One adult study (Cingi 2015) reported the number
of people who were classed on the ACT as ’well controlled’. The
effect favoured home telemonitoring and feedback, but the CI
included the possibility that the effect may be the same as that for
usual monitoring (OR 2.46, 95% CI 0.94 to 6.41).
Overall we had very low confidence in asthma control outcomes
owing to inconsistency both within outcomes and between them
in terms of direction and magnitude of effects. In addition, impre-
cision in most of the estimates made them difficult to interpret,
and the nature of these subjective scales means that they may be
subject to performance and detection biases associated with in-
ability to blind the interventions.
Serious adverse events (including mortality)
None of the studies recorded serious adverse events separately from
asthma exacerbations, and none reported whether anyone died
during the study.
Subgroup analysis and investigation of heterogeneity
Mean age (< 16 years, 17 to 65 years, > 65 years)
Two child studies (Deschildre 2012; Xu 2010) and two adult stud-
ies (Donald 2008; Ryan 2012) contributed to the primary out-
come of requiring oral corticosteroids, and the test for subgroup
differences did not indicate a difference in effects (I2 = 0%, P value
= 0.78). Two child studies (Guendelman 2002; Xu 2010) and six
adult studies (Donald 2008; Kokubu 2000; Liu 2011; Ryan 2012;
van der Meer 2009; Willems 2008) contributed to the exacerba-
tion requiring ED visit analysis, and a large degree of heterogene-
ity was evident within each subgroup (I2 = 62%, P value = 0.11;
I2 = 53%, P value = 0.06). As above, the test for subgroup differ-
ences for exacerbations requiring hospital admission analysis sug-
gests that adults may fare better with home telemonitoring than
children. It was not possible to subgroup the asthma control or
serious adverse event outcomes to investigate the effects of age.
Type of technology (telephone calls, text messages, emails)
We divided studies by type of technology used, for the purpose of
subgroup analysis, but we found nearly asmany subgroups as stud-
ies, so it was not possible to draw any conclusions about whether
the type of technology influenced the effect on exacerbations re-
quiring oral steroids (Analysis 2.1; Analysis 2.2; Analysis 2.3).
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Sensitivity analyses
Studies recruiting people with severe or life-threatening
asthma
Deschildre 2012, Kokubu 2000, and Xu 2010 contributed to the
primary analyses that listed inclusion criteria requiring popula-
tions with severe asthma. Deschildre 2012 and Xu 2010 were the
only child studies contributing to Analysis 1.1, and when they
were removed, the pooled effect was very similar (OR 0.93, 95%
CI 0.60 to 1.44 with; OR 0.90, 95% CI 0.54 to 1.50 without).
Removing Kokubu 2000 and Xu 2010 from the exacerbation re-
quiring ED visit analysis did not change the interpretation (OR
0.75, 95% CI 0.36 to 1.58 with; OR 0.65, 95% CI 0.27 to 1.59
without). When all three studies (Deschildre 2012; Kokubu 2000;
Xu 2010) were removed from the exacerbation requiring hospi-
talisation outcome, the overall effect showed a similar magnitude
but became more imprecise (OR 0.56, 95% CI 0.21 to 1.49, to
OR 0.58, 95% CI 0.13 to 2.56). These studies did not contribute
to the asthma control or serious adverse events primary analyses.
Unpublished data (obtained from trial authors or from
conference abstracts)
We obtained none of the data in the primary outcome analyses
from trial authors or from conference abstracts, so this sensitivity
analysis was not necessary.
Studies at high risk of detection bias
We considered only three studies (Donald 2008; Ryan 2012;
Young 2012) to be at low risk for detection bias, and they con-
tributed only to the exacerbations outcomes, which are unlikely
to have been affected by this type of bias. For these reasons, we
did not conduct the sensitivity analysis.
Secondary outcomes
Asthma-related quality of life
People in the telemonitoring with feedback groups scored better
on the AQLQ than those monitored in the usual way (MD 0.23,
95%CI 0.01 to 0.45; 796 participants; six studies; I2 = 54%). The
MCID on the scale is 0.5 units. We downgraded our confidence
in the result to low because of the potential for performance and
detection bias in the measure, and because we noted important
variation between study results.
Kokubu 2000 reported a change in the JapaneseMinistry ofHealth
andWelfare asthma quality of life score. We chose not to combine
this with the AQLQ data using SMD, because this change score
was obtained on a different scale, and we could not find details of
properties of the measure.
Lung function
Home telemonitoring with feedback showed an overall benefit
on lung function compared with usual monitoring, measured as
percentage predicted pre-bronchodilator forced expiratory volume
in one second (FEV1) (MD 7.21, 95% CI 1.52 to 12.89; 149
participants; three studies; I2 = 0%) and change in peak expiratory
flow (PEF) (MD 13.20, 95% CI 0.58 to 25.82; 66 participants;
one study).
van der Meer 2009 reported FEV1 as litres change from baseline,
which could not be pooled with results of the other studies. This
study showed a 240 mL mean increase from baseline in the home
telemonitoring group (SD 810 mL) and a 10 mL mean decrease
in the control group (SD 752 mL). Additionally, Voorend-van
Bergen 2015 reported several lung function parameters as z-scores
in the paper; we could not use the absolute final scores, as we
observed a significant baseline imbalance between groups.
Unscheduled healthcare visits
Variation between study results made the pooled effect difficult
to interpret (OR 0.99, 95% CI 0.37 to 2.62; 430 participants;
three studies; I2 = 73%), but telemonitoring did not lead to a clear
increase or decrease in the number of people making unscheduled
healthcare visits. We had very low confidence in the result owing
to imprecision of the estimate, attrition bias and important het-
erogeneity.
Deschildre 2012 reported data as the mean number of unsched-
uled visits per participant, which could not be pooled with di-
chotomous data. The study showed a slightly higher rate of un-
scheduled visits in the home telemonitoring group (mean 5.24,
SD 3.62) compared with the usual care group (mean 4.43, SD
4.13).
Adverse events/side effects
As with serious adverse events, none of the studies explicitly re-
ported adverse events as an outcome separate from asthma-related
adverse outcomes.
D I S C U S S I O N
Summary of main results
Home telemonitoring with feedback might be better or worse
than usual monitoring for exacerbations requiring a course of oral
steroids (odds ratio (OR) 0.93, 95% confidence interval (CI) 0.60
to 1.44; 466 participants; four studies), a visit to the emergency
department (OR 0.75, 95% CI 0.36 to 1.58; 1018 participants;
eight studies) or a hospital stay (OR 0.56, 95% CI 0.21 to 1.49;
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1042 participants; 10 studies). Our confidence in the results was
reduced owing to wide confidence intervals, which meant that we
could not rule out important benefits or harms of the intervention.
Evidence for measures of asthma control was patchy and did not
show a consistent direction of effect, with most studies not using
validated measures that could be pooled. We noted imprecision in
the estimates, and the nature of these subjective scales means they
may be subject to performance and detection bias associated with
inability to blind the interventions.
None of the studies recorded serious or non-serious adverse events
separately from asthma exacerbations, and none reported whether
anyone died during the studies; this is a limitation of the evidence.
Researchers have been concerned that this type of increased mon-
itoring can lead to a false sense of security, actually increasing ad-
verse events and the need for emergency care, which does not seem
to be the case. However, the benefits of home telemonitoring are
modest at best, given the resources and infrastructure required to
implement them.
With the exception of hospital admissions, adult and child stud-
ies showed similar findings, and too few studies with too much
variation in the interventions used prevented any meaningful con-
clusions about which types of technology may offer the greatest
benefit.
Within the secondary outcomes, people in the telemonitoring
groups scored better on the Asthma Quality of Life Questionnaire
(AQLQ) than those monitored in the usual way (mean difference
(MD) 0.23, 95% CI 0.01 to 0.45; 796 participants; six studies; I
2 = 54%), but study results showed important variation, and even
the upper CIs did not reach what is considered to be a meaningful
difference on the scale (0.5 units). Some benefit of home telemon-
itoring on lung function was apparent.
Overall completeness and applicability of
evidence
The field of telehealthcare is rapidly growing, and national health
systems are pushing to bring home telemonitoring interventions
into widespread practice; this explains the number of studies that
met our inclusion criteria. We deliberately refined the question in
such a way that we would exclude studies of automated monitor-
ing based on algorithms, monitoring as part of broad telehealth
interventions that included all manner of education and adherence
modules and sharing of symptom data to inform asthma man-
agement. That said, some of the included study interventions did
involve components that may have confounded the comparison
we set out to measure (e.g. an asthma education page within a
monitoring website, clinician decision support to interpret mon-
itoring data). We focused on telemonitoring interventions that
required clinician input to make the evidence easier to apply to
real clinical situations, but the number of excluded studies illus-
trates the breadth and complexity of this growing field of health
care, along with the evidence that has not been considered in this
review. Moreover, communication technologies for interventions
with another primary focus such as education, compliance or in-
haler technique have not been considered, and this splitting may
cause difficulty for decision makers in a field that is as varied and
dynamic as the technologies themselves (Rada 2015).
Some of the adult studies recruited people with severe or uncon-
trolled asthma (Deschildre 2012; Kokubu 1999; Kokubu 2000;
Prabhakaran 2009; Ryan 2012), but most did not specify, and
we found a mix both within and across analyses. This has impli-
cations for services that seek to implement monitoring strategies
such as these, because we cannot be sure whether people who have
regular exacerbations would derive the greatest benefit from extra
monitoring, or in fact whether they are more likely to be harmed
by the weakened responsibility patients feel in terms of their own
health. A related issue is the small number of studies reporting
what we considered to be the most important outcomes (i.e. those
prespecified in our review protocol), in particular, lack of explicit
reporting of adverse events, which may be related to the frequency
of these events expected in different populations. Other sources of
variation such as the nature of the control group (e.g. provision of
an action plan in Ryan 2012) and the frequency of planned and
actual feedback provided by healthcare professionals also make the
results difficult to apply to practice. We did not seek to explore
uptake, acceptability, equity of access and persistence in use, all of
which are important determinants of how an intervention may be
applied to a real-life setting.
Quality of the evidence
Our confidence in the evidence based onGRADE (Grades of Rec-
ommendation, Assessment, Development and Evaluation Work-
ing Group) quality ratings ranged frommoderate to very low, with
none of the analyses thought to be of high quality.
When considering the effects of risk of bias on evidence quality, we
noted that most of the high risk of bias judgements involved the
blinding domains, which reduced our confidence only for subjec-
tive outcomes (asthma control and quality of life). We also noted
some issues with high or unbalanced dropout in some studies, al-
though we considered this to have affected only the lung function
and unscheduled healthcare visits analyses, for which high-risk
studies carried a lot of weight. For one of the primary outcomes -
exacerbations requiring oral steroids - a couple of the contributing
studies had high attrition and uncertainty with selection bias, but
they carried less than a fifth of the overall weight, so we did not
judge this as serious enough to warrant a downgrade.
Inconsistency between study results was a problem in several of
the analyses (asthma control, exacerbations requiring emergency
department (ED) visits and hospital admissions, quality of life and
unscheduled healthcare visits) and could not be explained in most
cases by planned subgroup analyses for age or type of technology.
This may reflect the variation in any number of factors related to
the studies, such as baseline characteristics of recruited popula-
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tions, countries in which studies were conducted, length or details
of monitoring strategies used, the way outcomes were measured,
the nature of the control group and the presence of action plan
usage in the interventions. Picking apart each of these factors sta-
tistically was not possible, given the relatively small number of
studies included in any one analysis.
We did not downgrade the quality of evidence for any outcome
for its indirectness to the study question, because we were careful
to implement the study inclusion criteria as planned. Therefore,
we considered the populations, interventions, comparison groups
and outcomes of the studies included in the review to reflect well
the question we set out to answer.
Imprecision was perhaps the most limiting factor in this body of
evidence, which made results difficult to interpret. This was due to
the relatively small number of participants whose data contributed
to most of the analyses. In several outcome analyses, confidence
intervals (CIs) included the possibility that carrying on as usual was
at least as good as and potentially better than providing additional
telemonitoring and tailored feedback. In these cases, one cannot
say for certain whether additional monitoring will mean patients
will do better, or that it definitely will not make them worse, for
example, by removing personal responsibility and making them
less likely to take action when it is needed.
Several of the pooled estimates were made less precise mainly by
variation in the direction andmagnitude of individual study results
that could not be explained by planned subgroup analyses; this
was reflected in the downgrade decisions for inconsistency.
We suspected that publication bias might have affected only the
exacerbations requiring oral steroids analysis, as the number of
studies reporting this outcome was smaller than the number in-
cluded in similar analyses of exacerbations requiring ED visits
or hospital admissions, suggesting that oral steroid courses might
have been recorded and not reported. Although several other anal-
yses included only data from a small number of the 18 included
studies, we were able to rule out publication bias in most cases by
checking measured outcomes directly with study authors.
Potential biases in the review process
We recorded any deviations from the published protocol and ex-
plained why we believed it was not possible or meaningful to do
what was planned. However, a degree of subjectivity in the appli-
cation of study eligibility criteria was unavoidable. In the protocol,
we tried to outline as best as possible the type of intervention and
control that would answer the question we were examining, but
we could not anticipate the complexity of the interventions and
all the ways they would differ. Once a short list had been made via
the title and abstract sift, we spent time discussing each title and
paper for inclusion or exclusion and revisited previous decisions to
ensure consistency. Thus, we have recorded a long list of excluded
studies that we had to examine in detail, which we intend will help
readers understand the sifting process. When devising the original
short list, we sifted independently to reduce bias, and we collated
a large number of additional references from trial registries and
related works to make the list of included studies as complete as
possible.
Once the list of included studies had been decided, we contacted
study authors to clarify anything about the interventions and study
methods that was uncertain, and to ask for additional unpublished
data to reduce publication bias in the analyses. We translated non-
English language papers in duplicate with a structured data ex-
traction form based on the one used for all other studies.
Agreements and disagreements with other
studies or reviews
Systematic reviews of the evidence for remote or telehealth inter-
ventions have grappled with the clinical applicability of a narrow
research question with the completeness of a broad one. Meta-
analyses and narrative syntheses generally focus on a given in-
tervention for a broader population (e.g. respiratory disease) or
all long-term health conditions, or look broadly at interventions
delivered via technology for a given condition regardless of their
purpose. These broader reviews are difficult to compare with our
own, as they compile evidence for interventions that often need
to be assessed in quite different ways. For example, when assessing
the feasibility of providing an annual asthma checkup over the
phone, one wants to know whether patients are at risk of adverse
outcomes by removing face-to-face contact (Kew 2016). This is
different from assessing possible improvements in asthma control
by using electronic devices to improve adherence (Craven 2015),
and from using technology to monitor symptoms to minimise the
need for rescue oral steroids or emergency treatment. The first
approach is applied to look for equivalent efficacy, and the other
approaches, as is the case in the current review, to look for superi-
ority of technological interventions.
McLean 2010 looked at all ’telehealth’ interventions for asthma re-
gardless of their constituent parts or comparators used, and found
21 studies.McLean 2010 noted the clinical heterogeneity and con-
cluded that telehealth interventions are not likely to be of bene-
fit for patients with relatively mild asthma. Similarly, Zhao 2014,
which included six studies, noted that asthma function scores were
not improved by ’telemedicine’ interventions. Despite differences
in study inclusion criteria, the conclusions of these reviews are
largely consistentwith our own,with home telemonitoring or ’tele-
health’ interventions failing to show clear benefit over controls.
Jaana 2009 conducted a review of monitoring interventions more
similar to what we set out to assess in this review; however, that
review included people with other respiratory illnesses and out-
comes focused on patient attitudes and receptiveness rather than
effectiveness and safety. The review authors emphasized the “vari-
ations in study approaches and an absence of robust study designs
and formal evaluations”, which describes a common problem for
syntheses in this rapidly evolving area.
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A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Current evidence does not support the widespread implementa-
tion of telemonitoring with healthcare provider feedback between
asthma clinic visits. Studies have not yet proved that additional
telemonitoring strategies lead to better symptom control or re-
duced need for oral steroids over usual asthma care, nor have they
ruled out unintended harms. Investigators have reported small
benefits in quality of life, but these are subject to a risk of bias,
as the studies were unblinded. Similarly, some benefits for lung
function are uncertain owing to possible attrition bias.
Implications for research
Larger pragmatic studies in children and adults could better deter-
mine the real-world benefits of these interventions for preventing
exacerbations and avoidingharms; it is difficult to generalise results
from this review because benefits may be explained at least in part
by the increased attention participants receive when taking part
in clinical trials. Qualitative studies could inform future research
by focusing on patient and provider preferences or by identifying
subgroups of patients who are more likely to derive benefit from
closer monitoring, such as those who have frequent attacks.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Bateman 2000
Methods Study design: 12-month parallel RCT
Setting: practices in South Africa
Participants Population: 135 participants were randomised to telemonitoring (68) or to control (67)
Baseline characteristics
Mean age (SD): NR
% male: NR
Inclusion criteria: people withmoderate or severe asthmawhohad direct asthma-related
expenditure of > USD 150 during the preceding year
Exclusion criteria: NR
Interventions Intervention: PAP, a comprehensive computerised interactive guideline-based clinical
decision support system to which patients are linked telephonically by modem to permit
daily monitoring of home spirometry and other clinical details by a healthcare coordi-
nator. PAP provides the practitioner with regular status reviews and treatment recom-
mendations, along with education for patients
Control: Patients remained under the usual care of practitioners
Outcomes Quality of life (Juniper scale), healthcare utilisation, direct costs of care
Notes Funding: NR
No full paper available, only conference abstract
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Described as randomised, but method used
to generate the random sequence not de-
scribed
Allocation concealment (selection bias) Unclear risk No information regarding allocation con-
cealment
Blinding of participants and personnel
(performance bias)
Objective outcomes
Low risk It would not have been possible to hide al-
location from participants and personnel,
but it is unlikely that this would have in-
troduced bias for objective outcomes (e.g.
number of people having exacerbations)
Blinding of participants and personnel
(performance bias)
Subjective outcomes
High risk Subjective outcomes such as quality of life
and symptom scales filled in by participants
or personnel may have been subject to per-
formance bias
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Bateman 2000 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
High risk It would have been possible to blind out-
come assessors, but no information sug-
gests this was done
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Dropout not reported
Selective reporting (reporting bias) High risk Only an abstract was available with min-
imal information about methods and no
useable outcome data relevant to the review
Other bias Low risk None noted
Cingi 2015
Methods Study design: 12-month multi-centre prospective, double-blind parallel RCT
Setting: conducted from June 2013 to December 2013 in pulmonary disease university
departments and research hospitals in Turkey
Participants Population: 136 participants with asthma were randomised to telemonitoring (68) or
to control (68), and 191 people with allergic rhinitis were randomised separately and
not included in this review
Baseline characteristics
Mean age (SD): telemonitoring 32.0 (3.7); control 34.5 (8.2)
% male: telemonitoring 50.0%; control 41.4%
Inclusion criteria: diagnosis of mild to severe persistent asthma according to the Global
Initiative for Asthma (GINA) classification upon presentation at outpatient clinics. Pa-
tients were required to own a smartphone and to consent to participation in a study
researching the impact of mobile communication on disease management
Exclusion criteria: pregnancy, breastfeeding, failure to provide consent
Interventions Intervention: mobile phone app allowing participants to fill out health status, send
urgent messages to the physician or post information, medicine alerts and option to
record adherence
Control:Control groups received an application that allowed completion of the Asthma
Control Test only at the beginning and end of the trial and did not include commu-
nication or health status or medication usage tracking. Physicians communicated with
control group participants using only conventional methods upon participant request;
these communications were recorded as study findings
Participants in both groups received standard treatment during the study period, accord-
ing to treatment guidelines
Outcomes ACT (median scores and % scoring < 20 at endpoint), unplanned health visits, satisfac-
tion scores, communication times
Notes Funding: “There was no funding source”
Risk of bias
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Cingi 2015 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Randomization was performed by sim-
ple randomization using a random number
generator”
Allocation concealment (selection bias) Low risk “The participating patient list was shared
with POPET LLC (only the initials, age,
gender, diagnosis, treatment plan of the
patients), which randomized the patients
daily to their respective groups”
Blinding of participants and personnel
(performance bias)
Objective outcomes
Low risk “Patients were blinded to the type of soft-
ware (POPET or control) they would re-
ceive and were not trained in the use of the
application in the clinic setting”
This effort to blind would have controlled
for someperformance bias, but participants
may have worked out that they were in an
intervention or control group by what they
had access to. It is unlikely that this would
have introduced bias for the objective out-
comes (e.g. number of people having exac-
erbations)
Blinding of participants and personnel
(performance bias)
Subjective outcomes
High risk “Patients were blinded to the type of soft-
ware (POPET or control) they would re-
ceive and were not trained in the use of the
application in the clinic setting”
This effort to blind would have controlled
for someperformance bias, but participants
may have worked out that they were in an
intervention or control group by what they
had access to. This may have affected sub-
jective rating scales
Blinding of outcome assessment (detection
bias)
All outcomes
High risk This trial was described as double-blind,
but the main outcome was a rating scale
completed by participants who, by the na-
ture of the intervention, could have worked
out if they were in the intervention or con-
trol group
Incomplete outcome data (attrition bias)
All outcomes
High risk “Patients who did not complete the final
survey were excluded from the analysis and
reported as attrition”
“In total, 88.2% (n = 60) of the interven-
tion group and 42.6% (n = 29) of the con-
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Cingi 2015 (Continued)
trol group of asthma patients finished the
trial”
Selective reporting (reporting bias) Low risk Named outcomes were reported, but some
could not be included inmeta-analysis with
the other studies owing to the statistical
methods used (z-scores and non-paramet-
ric tests)
Other bias Low risk None noted
Deschildre 2012
Methods Study design: 12-month parallel RCT
Setting: Paediatric Pulmonary Unit, Hospital Jeanne de Flandre, University Hospital,
Lille, and 3 paediatric departments in the Nord-Pas de Calais region
Study ran from January 2003 to December 2007
Participants Population: 50 children and adolescents randomised to telemonitoring (25) or to con-
ventional treatment control (25)
Baseline characteristics
Median age: telemonitoring 11.0; control 11.2
% male: telemonitoring 72; control 76
Inclusion criteria: children aged 6 to 16 years with severe allergic asthma according to
the Third Paediatric Asthma Consensus (i.e. frequent acute episodes requiring oral corti-
costeroid therapy, associated with moderate episodes (exercise-induced asthma, chronic
cough, sleep disturbances, treatment with short-acting b2-agonists 3 times per week) and
airflow limitation). All children had uncontrolled asthma when taking long-acting beta-
agonists and inhaled corticosteroids with frequent severe exacerbations. Reversibility in
FEV1, defined as reversibility > 12% and/or an increase of ≥ 200 mL
Exclusion criteria: congenital or acquired chronic illnesses other than asthma
Interventions Intervention: Children’s treatment was managed with daily home spirometry transmit-
ted to the physician via modem, along with medical feedback. The general practitioner
was contacted, if needed, in the case of FEV1 values of 60% to 80% predicted. In cases of
FEV1 < 60% predicted, the physician judged whether a course of oral corticosteroids was
rapidly required and informed or contacted the general practitioner or the paediatrician
who followed the child at the hospital
Control: conventional treatment (i.e. no additional monitoring and feedback from
physician)
Outcomes Exacerbations requiring a course of oral steroids, unscheduled visit to a physician or ED
or hospitalisation, number of days of corticosteroid treatment, daily dose of ICS, lung
function measures, paediatric AQLQ
Measured at the end of 12 months and at 4-month checkups, spirometry every day
Notes Funding: grant from the French Ministry of Health
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Deschildre 2012 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Random allocation to HM or CT group
was performed at inclusion, resulting in
groups of 6 participants at each investiga-
tion centre
Allocation concealment (selection bias) Unclear risk No information regarding allocation con-
cealment
Blinding of participants and personnel
(performance bias)
Objective outcomes
Low risk It would not have been possible to hide al-
location from participants and personnel,
but it is unlikely that this would have in-
troduced bias for objective outcomes (e.g.
number of people having exacerbations)
Blinding of participants and personnel
(performance bias)
Subjective outcomes
High risk Subjective outcomes such as quality of life
and symptom scales filled in by participants
or personnel may have been subject to per-
formance bias
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Investigators were not blind and appear to
be those taking measurements
Incomplete outcome data (attrition bias)
All outcomes
High risk Attrition was much higher in the telemon-
itoring group (40%) than in the usual care
group (20%), and only those dropping out
after 120 days were included in the fi-
nal analysis, representing 88% of the ran-
domised sample
Selective reporting (reporting bias) Low risk All outcomes were reported but could not
be included in the meta-analysis, as non-
parametric tests were used (which was ap-
propriate for the study data)
Other bias Low risk None noted
Donald 2008
Methods Study design: 12-month parallel RCT
Setting: 2 teaching hospitals in Australia
Pariticpants were recruited between 1 May 201 and 30 November 2003
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Donald 2008 (Continued)
Participants Population: 71 participants were randomised to telemonitoring (36) or to control (35)
Baseline characteristics
Mean age (SD): telemonitoring 36.2 (NR) - groups combined
% male: telemonitoring 23.9 - groups combined
Inclusion criteria: aged 18 to 55 years and admitted to 1 or both of 2 teaching hospitals
with a primary diagnosis of asthma
Exclusion criteria: another chronic respiratory condition, an unstable medical condi-
tion, a cognitive or intellectual disability, psychiatric illness, unable to speak English
Interventions Intervention: 6 follow-up telephone calls from the nurse educator to ask about current
asthma symptoms and to give advice on their management. All participants received a
PEFmeter and instructions onhow to record their results. All participants attended a face-
to-face sessionwith an asthma nurse educator and received advice on the pathophysiology
of asthma, medications, triggers and self management, and were given an Asthma Action
Plan
Control: The control group was encouraged to continue with self management and
usual GP care
Outcomes Hospital admissions at recruitment, written plan and PEFmonitor ownership, delivery of
management sessions, healthcare utilisation, days lost from work or study, exacerbations
requiring use of oral steroids, healthcare costs
Notes Funding: NR
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Described as randomised, but method used
to generate the random sequence not de-
scribed
Allocation concealment (selection bias) Unclear risk No information regarding allocation con-
cealment
Blinding of participants and personnel
(performance bias)
Objective outcomes
Low risk It would not have been possible to hide al-
location from participants and personnel,
but it is unlikely that this would have in-
troduced bias for objective outcomes (e.g.
number of people having exacerbations)
Blinding of participants and personnel
(performance bias)
Subjective outcomes
High risk Subjective outcomes such as quality of life
and symptom scales filled in by participants
or personnel may have been subject to per-
formance bias
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “All participantswere telephonedweekly by
a researcher (blinded to participant alloca-
tion)”
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Donald 2008 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
High risk 71 participants were randomised; 44 replies
were received at 6 months and 49 at 12
months. No description of how data were
modified or imputed for those not con-
tributing to the analyses
Selective reporting (reporting bias) Low risk Outcomes named in themethods were well
reported in the results section, although
this could not be verified with a protocol
Other bias Low risk None noted
Finkelstein 2005
Methods Study design: 12-month parallel RCT
Setting: NR
Participants Population: 240 participants were randomised to telemonitoring (NR) or to control
(NR)
Baseline characteristics
Mean age (SD): NR
% male: NR
Inclusion criteria: age 18 and older with mild persistent to severe asthma
Exclusion criteria: NR
Interventions Intervention: “Home Automated Telemanagement” (HAT). Participants used portable
computers connected with a peak flow meter to report their symptoms and to commu-
nicate with their provider. The HAT systemmonitored participants’ asthma severity and
assisted in carrying out individualised asthma action plans
Control: usual care, not described
Outcomes ’Clinical outcomes’ - Those reported in abstract include AQOL symptoms domain and
activities domain, CSQ, depression on CESD-D, number of ED visits (not people) per
2 months
Notes Funding:USNational Institutes of Health (NIH) and National Heart, Lung, and Blood
Institute (NHLBI)
No full paper available, only conference abstract
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Described as randomised, but method used
to generate the random sequence not de-
scribed
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Finkelstein 2005 (Continued)
Allocation concealment (selection bias) Unclear risk No information regarding allocation con-
cealment
Blinding of participants and personnel
(performance bias)
Objective outcomes
Low risk It would not have been possible to hide al-
location from participants and personnel,
but it is unlikely that this would have in-
troduced bias for objective outcomes (e.g.
number of people having exacerbations)
Blinding of participants and personnel
(performance bias)
Subjective outcomes
High risk Subjective outcomes such as quality of life
and symptom scales filled in by participants
or personnel may have been subject to per-
formance bias
Blinding of outcome assessment (detection
bias)
All outcomes
High risk It would have been possible to blind out-
come assessors, but no information sug-
gests this was done
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Dropout not reported, only interim data
for first 50 participants recruited
Selective reporting (reporting bias) High risk Only an abstract was available with mini-
mal information about methods. Two con-
ference abstracts from 2005 report data
for the first 50 participants to complete 4-
month follow-up. No data are available for
the full population of 240 enrolled in the
study, and none for the full 12 months of
the trial
Other bias Low risk None noted
Guendelman 2002
Methods Study design: 3-month parallel RCT
Setting: 1 clinic in California, USA
Participants were recruited between April 1999 and July 2000
Participants Population: 134 participants were randomised to telemonitoring (66) or to control (68)
Baseline characteristics
Mean age (SD): telemonitoring 12.0 (2.3); control 12.2 (2.9)
% male: telemonitoring 61; control 54
Inclusion criteria: Children were eligible for inclusion in the study if they were 8 to
16 years of age and had an English-speaking caregiver, a telephone to the house and
persistent asthma
Exclusion criteria: involved in other asthma or drug efficacy studies, involved in research
that required behaviour modification, had mental or physical challenges that made it
difficult to use the Health Buddy. Children with co-morbid conditions that could affect
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Guendelman 2002 (Continued)
their quality of life were also excluded
Interventions Intervention:Health Buddy device, a computerised interactive asthma self management
and education programme that connected to the Internet and asked every day about
asthma status, peak flow and medication. Responses were downloaded overnight to the
nurse co-ordinator. Devices were interactive and gave immediate feedback on questions
regarding asthma symptoms, medications, PEF and other items
Control: Paper asthma diary. All children returned for 2 follow-up visits at 6 and 12
weeks, when they received further standardised teaching from the nurse co-ordinator
Outcomes Limitation in activity, asthma symptoms, missed school days, PEFR, healthcare utilisa-
tion including ED visits and hospitalisations. Measured at 0, 6 and 12 weeks
Notes Funding: NR
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information, “randomised”
Allocation concealment (selection bias) Low risk “Following baseline interview the nurse
opened a sealed envelope containing the
treatment assignment”
Blinding of participants and personnel
(performance bias)
Objective outcomes
Low risk It would not have been possible to hide al-
location from participants and personnel,
but it is unlikely that this would have in-
troduced bias for objective outcomes (e.g.
number of people having exacerbations)
Blinding of participants and personnel
(performance bias)
Subjective outcomes
High risk Subjective outcomes such as quality of life
and symptom scales filled in by participants
or personnel may have been subject to per-
formance bias
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Self reported outcomes were assessed by the
nurse co-ordinator, no blinding
Incomplete outcome data (attrition bias)
All outcomes
Low risk Baseline characteristics of children who did
and did not complete the trial did not dif-
fer. 62/66 participants in the intervention
group and 60/68 participants randomised
to the control group completed 12 weeks.
Reasons for dropping out of the study in-
cluded moving out of the area (n = 3) and
life crisis (n = 4). Five familles who dropped
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Guendelman 2002 (Continued)
out could not be contacted
Selective reporting (reporting bias) Low risk All primary and secondary outcomes are
reported
Other bias Low risk None noted
Jan 2007
Methods Study design: 3-month parallel RCT
Setting: 1 paediatric allergy and asthma clinic in Taiwan
Study was conducted between January and December 2004
Participants Population:164participantswere randomised tohome telemonitoring (88) or to control
(76)
Baseline characteristics
Mean age (SD): monitoring 10.9 (2.5); control 9.9 (3.2)
% male: monitoring 39.7; control 36.8
Inclusion criteria: Children were eligible for inclusion in the study if they were between
the ages of 6 and 12 years, were given access to the Internet by their caregivers and had
a physician’s diagnosis of asthma
Exclusion criteria: other chronic conditions such as bronchopulmonary dysplasia
Interventions Intervention: “Blue Angel for Asthma Kids”, an Internet-based paediatric asthma mon-
itoring programme for asthmatic children and their parents. The system has symptom
and peak flow diaries and individual Asthma Action Plan suggestions based on GINA
(Global Initiative for Asthma) guidelines. These data can be shared with the patient’s
physician, who can give feedback via telephone or email
Control: traditional treatment in an outpatient allergy and asthma clinic accompanied
by a PEF meter and diary. This group also received asthma education as part of usual
care, including verbal and printed information. Individuals were given an AsthmaAction
Plan to aid decision making
Outcomes PEF records, symptom diaries, paediatric QoL test, childhood asthma control test, care-
giver survey of asthma knowledge, adherence to treatment, asthma diaries
Notes Funding: supported in part by a grant from the National Science Council (NSC 94-
2815-C-426-005-E) and by a grant from the Bureau of Health Promotion, Department
of Health (DOH 93-HP-1124), Taiwan, R.O.C
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Children and their caregivers, who were
randomised”
No details of methods used to generate the
sequence
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Jan 2007 (Continued)
Allocation concealment (selection bias) Low risk Sealed envelope
Blinding of participants and personnel
(performance bias)
Objective outcomes
Low risk It would not have been possible to hide al-
location from participants and personnel,
but it is unlikely that this would have in-
troduced bias for objective outcomes (e.g.
number of people having exacerbations)
Blinding of participants and personnel
(performance bias)
Subjective outcomes
High risk Subjective outcomes such as quality of life
and symptom scales filled in by participants
or personnel may have been subject to per-
formance bias
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No information is given as to how out-
comes of the groups were collected, and
whether outcome assessors were blinded
to allocation of participants. Blinding
would not have been possible for outcomes
recorded by the Internet programme, but
would have been possible for outcomes
recorded via questionnaires at baseline and
at 12 weeks
Incomplete outcome data (attrition bias)
All outcomes
Low risk Of 164 randomised, 82/88 in the interven-
tion arm (93.2%) and 71/76 in the con-
trol arm (93.4%) completed the study, rep-
resenting relatively low and balanced attri-
tion
Selective reporting (reporting bias) Low risk Satisfaction questionnaires data not shown,
but this was not one of the review’s named
outcomes
Other bias Low risk None noted
Kokubu 1999
Methods Study design: 6-month parallel RCT
Setting: Japanese medical centres
Participants Population: 50 participants were randomised to home telemonitoring (24) or to control
(26)
Baseline characteristics
Mean age (SD): monitoring 54.2 (14.3); control 51.5 (14.9)
% male: monitoring 66.7; control 26.9
Participants had a mean duration of asthma of around 17 years, ICS mean dose of 1000
mcg/d and 11 ED visits in past year
Inclusion criteria: Patients with high hospitalisation risk were enrolled in the study
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Kokubu 1999 (Continued)
upon screening for those with multiple previous emergency room visits
Exclusion criteria: not available from the translation
Interventions Intervention: telemedicine system to monitor airway status at home for participants
with poorly controlled asthma, whereby a nurse provides instructions to individuals via
telephone to help them manage exacerbation under the supervision of physicians
Control: description not available from translation - presumed to be usual care
Outcomes Number of emergency room visits (reported only as the number per patient per year,
which could not be pooled), activities of daily living, PEF
Notes Funding: unclear
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Described as randomised, but details of
how the sequence was generated not de-
scribed
Allocation concealment (selection bias) Low risk Randomisation was done by telephone call
to the registration centre
Blinding of participants and personnel
(performance bias)
Objective outcomes
Low risk It would not have been possible to hide al-
location from participants and personnel,
but it is unlikely that this would have in-
troduced bias for objective outcomes (e.g.
number of people having exacerbations)
Blinding of participants and personnel
(performance bias)
Subjective outcomes
High risk Subjective outcomes such as quality of life
and symptom scales filled in by participants
or personnel may have been subject to per-
formance bias
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Trial was open label (from translator)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No information available
Selective reporting (reporting bias) Unclear risk Could not be determined from the transla-
tion
Other bias Low risk No other bias noted
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Methods Study design: 6-month parallel RCT
Setting: 17 tertiary care hospitals in Japan
Participants Population: 75 participants were randomised to home telemonitoring (37) or to control
(38)
Baseline characteristics
Mean age (SD): monitoring 49.9 (15.6); control 47.3 (13.6)
% male: monitoring 37.5; control 44.1
Participants had a mean duration of asthma of around 17 years, ICS mean dose of 1000
mcg/d and 6 ER visits in past year
Inclusion criteria: patients with asthma who were treated with sufficient inhaled steroid
therapy and were admitted to emergency department more than 3 times in past year
Exclusion criteria: COPD, chronic heart failure
Interventions Intervention: telemedicine system to monitor airway status at home for participants
with poorly controlled asthma, whereby a nurse provides instructions to individuals via
telephone to help them manage exacerbation under the supervision of their physicians.
Participants measured their PEF twice daily and sent this information to the nurse via the
system. Participants inhaled the corticosteroid when PEF was≥ 80%.When inhaled B2-
stimuli with the best PEF was between 60% and 80%, and when PEF did not recover up
to 80%, participants were instructed to inhale an increased dosage of corticosteroids or
to take oral corticosteroids. When the best PEF was < 60%, participants were instructed
to visit their physicians
Control: conventional asthma therapy including twice-dailymeasurement of PEF, which
was recorded in a diary and was not shared
Outcomes Hospitalisation, night and daytime ED visits, compliance with PEF measurements and
medications, PEFR, QoL
Notes Funding: unclear
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Described as randomised, but details of
how the sequence was generated not de-
scribed
Allocation concealment (selection bias) Low risk Randomisation was done by telephone to
the registration centre
Blinding of participants and personnel
(performance bias)
Objective outcomes
Low risk It would not have been possible to hide al-
location from participants and personnel,
but it is unlikely that this would have in-
troduced bias for objective outcomes (e.g.
number of people having exacerbations)
44Home telemonitoring and remote feedback between clinic visits for asthma (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
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Blinding of participants and personnel
(performance bias)
Subjective outcomes
High risk Subjective outcomes such as quality of life
and symptom scales filled in by participants
or personnel may have been subject to per-
formance bias
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Trial was open label (from translator), and
no information suggests outcome assessors
were blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk 5 people in the intervention group (13.
5%) and 4 people in the control group (10.
5%) did not complete the trial. These peo-
ple were not included in the analyses, but
dropout was fairly low and balanced, so was
not thought to pose significant risk of bias
Selective reporting (reporting bias) High risk Translator stated that some numerical data
were underreported and were “not usable
for meta-analysis”
Other bias Low risk None noted
Liu 2011
Methods Study design: 6-month parallel RCT
Setting: outpatient clinics of a teaching hospital in Taiwan
Participants Population: 120 participants were randomised to remote monitoring (60) or to control
(60)
Baseline characteristics
Mean age (SD): monitoring 50.4 (12.9); control 54.0 (15.7)
% male: monitoring 51.2; control 47.8
Inclusion criteria: participants with moderate to severe persistent asthma from outpa-
tient clinics of Chang Gung Memorial Hospital
Exclusion criteria: NR
Interventions Intervention:mobile telephone-based interactive self care software: electronic diary pro-
vided to record participants’ daily asthma symptom scores, use of relievers and lung
function measures. Management advice was given via GPRS on the basis of uploaded
data, in accordance with GINA guidelines. Participants and medical staff reviewed daily,
weekly and monthly data on the website. Data were given to physicians to adjust their
treatment plan when participants returned to their clinics
Control: written asthma diary and action plan. All participants received asthma educa-
tion, self management plan and standard treatment
Outcomes Quality of life on the SF-12, episodes of acute exacerbation and medications used for
asthma control on return visit, FEV1, FVC, asthma symptom score; numbers of un-
scheduled clinic visits, emergency department visits and hospitalisations
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Notes Funding: NR
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Described as randomised, but method used
to generate the random sequence not de-
scribed
Allocation concealment (selection bias) Unclear risk No information regarding allocation con-
cealment
Blinding of participants and personnel
(performance bias)
Objective outcomes
Low risk It would not have been possible to hide al-
location from participants and personnel,
but it is unlikely that this would have in-
troduced bias for objective outcomes (e.g.
number of people having exacerbations)
Blinding of participants and personnel
(performance bias)
Subjective outcomes
High risk Subjective outcomes such as quality of life
and symptom scales filled in by participants
or personnel may have been subject to per-
formance bias
Blinding of outcome assessment (detection
bias)
All outcomes
High risk It would have been possible to blind out-
come assessors, but no information sug-
gests this was done
Incomplete outcome data (attrition bias)
All outcomes
High risk Dropout was quite high and balanced be-
tween groups (28% and 23%). Outcomes
are reported for the 43 and 46 participants
completing the 6-month follow-up, not for
the 60 and 60 randomised
Selective reporting (reporting bias) Low risk Nomention of trial registration. Outcomes
stated in the methods were well reported
Other bias Low risk None noted
Ostojic 2005
Methods Study design: 4-month parallel RCT
Setting: 1 respiratory clinic in Croatia
Participants Population: 16 participants were randomised to home telemonitoring (8) or to control
(8)
Baseline characteristics
Mean age (SD): monitoring 24.8 (6.3); control 24.5 (7.1)
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% male: monitoring 63; control 50
Inclusion criteria: moderate persistent asthma for ≥ 6 months and treated with ICS
and LABA
Exclusion criteria: no history of smoking, chronic bronchitis or emphysema. Patients
without consistent access to a cell telephone or unable to use SMS were excluded
Interventions Intervention: Participants were told to note PEF, medication usage and symptoms in
a paper diary. PEF was to be done 3 times a day, then those in the text group would
send their results daily to a computer at the asthma centre. Both groups were treated
according to GINA guidelines, but the text group received weekly instructions by text
from an asthma specialist on adjustments to therapy as well as invitations, when required,
to come in for an extra office visit
Control: Controls also kept a daily diary of peak flow and symptoms, but their results
were reviewed by the physician only at the end of the study period upon attending the
physician’s office
Both groups were treated according to GINA guidelines
Outcomes Office pulmonary function test measurements, patient daily records of PEF and symp-
toms, details of asthma medication, PEF variability, cost, reliability of text. Measured at
baseline and at 16 weeks
Notes Funding: NR
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Patients were randomised by computer”
Allocation concealment (selection bias) Unclear risk No details about allocation concealment
Blinding of participants and personnel
(performance bias)
Objective outcomes
Low risk It would not have been possible to hide al-
location from participants and personnel,
but it is unlikely that this would have in-
troduced bias for objective outcomes (e.g.
number of people having exacerbations)
Blinding of participants and personnel
(performance bias)
Subjective outcomes
High risk Subjective outcomes such as quality of life
and symptom scales filled in by participants
or personnel may have been subject to per-
formance bias
Blinding of outcome assessment (detection
bias)
All outcomes
High risk It would have been possible to blind out-
come assessors, but no information sug-
gests this was done
Incomplete outcome data (attrition bias)
All outcomes
Low risk No evidence of incomplete outcome data;
no study withdrawals
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Selective reporting (reporting bias) Low risk Outcomes stated in the methods were well
reported, although a protocol was not avail-
able
Other bias Low risk None noted
Prabhakaran 2009
Methods Study design: 3-month parallel RCT
Setting: 1 hospital in Singapore
Participants were recruited between 1 August 2007 and 30 June 2008
Participants Population:120participantswere randomised tohome telemonitoring (60) or to control
(60)
Baseline characteristics
Mean age (SD): monitoring 37 (12); control 40 (13)
% male: monitoring 35; control 47
Inclusion criteria: 21 years of age or older, admitted for an acute exacerbation of asthma,
own a mobile phone, know how to use an SMS system, English speaking, willing to
participate in the study and give written consent
Exclusion criteria: significant co-morbidity e.g. bronchiectasis, heart failure, diabetes
mellitus with complications, stroke, renal impairment, COPD; did not know how to
use an SMS system, had mild intermittent asthma
Interventions Intervention: The 60 participants in the intervention group had SMS monitoring to
assist with management of their asthma control for the next 3 months
Control: The 60 participants in the control group were left to self manage their asthma
for 3 months
All 120 participants recruited were seen by a trained asthma nurse educator, who assessed
their asthma control, compliance with treatment and inhaler technique before providing
individualised asthma education
Outcomes Asthma Control Test, use of nebulisation, ED visits and hospital admissions for asthma
since the last admission 12 weeks previously
Notes Funding: NR
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Allocation was done from an envelope with
slips of paper. Participants had to draw
from the envelope to discover their allo-
cated group
Allocation concealment (selection bias) Unclear risk Unclear whether it was possible to predict
allocation from the slips used
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Blinding of participants and personnel
(performance bias)
Objective outcomes
Low risk It would not have been possible to hide al-
location from participants and personnel,
but it is unlikely that this would have in-
troduced bias for objective outcomes (e.g.
number of people having exacerbations)
Blinding of participants and personnel
(performance bias)
Subjective outcomes
High risk Subjective outcomes such as quality of life
and symptom scales filled in by participants
or personnel may have been subject to per-
formance bias
Blinding of outcome assessment (detection
bias)
All outcomes
High risk It would have been possible to blind out-
come assessors, but no information sug-
gests this was done
Incomplete outcome data (attrition bias)
All outcomes
Low risk “Since all patients received the inpatient
phase of asthma education, the intention-
to-treat approach was used to analyse the
secondary objective on clinical outcomes.
We were not able to contact three subjects
from the control group and two subjects
from the intervention group to assess their
asthma control and number of nebuliza-
tions. Nevertheless, information about the
number of emergency visits and hospital
admissions for asthma were retrieved for all
patients from the hospital computer sys-
tem”
Selective reporting (reporting bias) Low risk No study protocol found but named out-
comes well reported
Other bias Low risk None noted
Ryan 2012
Methods Study design: 6-month parallel RCT
Setting: 32 general practices in the UK
Participants Population: 288 participants were randomised to home telemonitoring (145) or to
control (143)
Baseline characteristics
Mean age (SD): monitoring 46.6 (18); control 51.5 (17.7)
% male: monitoring 33.8; control 41.3
Inclusion criteria: patients aged 12 and older who were registered with participating
practices, had poorly controlled asthma (defined as score ≥ 1.5 on the ACQ) and had,
or were willing to borrow, a compatible mobile phone handset and a contract with a
compatible network
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Exclusion criteria: other lung disease, unable to communicate in English, receiving
specialist care for severe/difficult asthma, general practitioner advised against inclusion
for major social/clinical problems
Interventions Intervention: twice-daily recording andmobile phone-based transmission of symptoms,
drug use and peak flow with immediate feedback prompting action according to an
agreed plan
Control: paper-based monitoring. “To ensure that our trial specifically tested the impact
of the technology, we opted to provide the paper group with the same clinical care as the
intervention group, rather than using (probably less intensive) usual care as a comparator.
” Both groups also received a 30-minute education session from the practice nurse before
randomisation
“The practices’ asthma nurse provided clinical care in accordance with the stepwise
approach advocated by the BTS-SIGN asthma guideline”
Outcomes ACQ, KASE-AQ, Mini-AQLQ, costs, adverse events, asthma ED attendances, asthma
hospitalisation, acute exacerbation, course of oral steroids, unscheduled healthcare at-
tendances, withdrawal. Measures taken at 6 months after randomisation
Notes Funding Asthma UK (project ID 07/047)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “All consenting participants were strati-
fied by practice and centrally randomised
(Health Services Research Unit, University
of Aberdeen) to mobile phone or paper
basedmonitoringwith a 1:1 allocationwith
random block sizes of two or four”
“All consenting participants were strati-
fied by practice and centrally randomised
(Health Services Research Unit, University
of Aberdeen) to mobile phone or paper
basedmonitoringwith a 1:1 allocationwith
random block sizes of two or four”
Allocation concealment (selection bias) Low risk “Telephone randomisation ensured con-
cealment until the treatment was assigned”
Blinding of participants and personnel
(performance bias)
Objective outcomes
Low risk “The practice nurse informed the patient
of allocation to ensure the researchers were
blinded to allocation throughout data col-
lection and analysis”
Participants could not be blinded, but it is
unlikely that this would have introduced
bias for objective outcomes (e.g. number of
people having exacerbations)
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Blinding of participants and personnel
(performance bias)
Subjective outcomes
High risk Subjective outcomes such as quality of life
and symptom scales filled in by participants
or personnel may have been subject to per-
formance bias
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “Assessment of outcomes was blinded. A
researcher blinded to allocation collected
primary outcome data at the final trial visit;
non-attendees were sent the questionnaires
by post”
Incomplete outcome data (attrition bias)
All outcomes
Low risk “Our main analysis was on an intention
to treat (ITT) basis. We assumed that par-
ticipants who did not attend the three or
six month assessment had not improved
their control and their previous results were
therefore carried forward.30 A per proto-
col analysis was undertaken as a sensitivity
analysis”
Selective reporting (reporting bias) Low risk “All analyses were agreed a priori. We did
not plan, or undertake, any interim analy-
sis”
Registered on clinicaltrials.gov
Other bias Low risk None noted
van der Meer 2009
Methods Study design: 12-month parallel RCT
Setting: 37 general practices in the Netherlands
Study ran from September 2005 to September 2006
Participants Population: 200 participants were randomised to home telemonitoring (101) or to
control (99)
Baseline characteristics
Mean age (SD): monitoring 36; control 37
% male: monitoring 32; control 29
Inclusion criteria: ages 18 to 50, prescription of inhaled corticosteroids for≥ 3 months
in the previous year, access to the Internet at home, mastery of the Dutch language
Exclusion criteria: not receiving maintenance oral glucocorticosteroid treatment, no
serious co-morbid conditions that interfered with asthma treatment
Interventions Intervention: Internet-based self management program. Participants measured FEV1
daily and reported the highest of 3 measurements before taking their medication. They
completed the Asthma Control Questionnaire (ACQ) once a week and reported symp-
toms via Internet or text. Participants monitored their asthma using the special website
or via text on a mobile phone, then used an Internet-based asthma treatment plan and
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online education, including asthma news, frequently asked questions and other infor-
mation. Participants could also communicate with a specialised asthma nurse using the
Web or telephone. The ACQ score was fed into an algorithm, and participants received
1 of 4 treatment messages
Control: Control participants had access to the part of the website on which a diary of
symptoms and exacerbations was kept
Outcomes Consumer Asthma Knowledge Questionnaire, inhaler technique, medication changes
per participant, healthcare utilisation, AQLQ, ACQ, symptom-free days, trough FEV1,
daily inhaled steroid dose, exacerbations
Notes Funding: NR
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Patients were randomly assigned us-
ing a computer-generated permuted-block
scheme”
Allocation concealment (selection bias) Unclear risk “Allocation took place by computer after
collection of the baseline data ensuring
concealment of allocation”
It is not clear whether this was central allo-
cation
Blinding of participants and personnel
(performance bias)
Objective outcomes
Low risk It would not have been possible to hide al-
location from participants and personnel,
but it is unlikely that this would have in-
troduced bias for objective outcomes (e.g.
number of people having exacerbations)
Blinding of participants and personnel
(performance bias)
Subjective outcomes
High risk Subjective outcomes such as quality of life
and symptom scales filled in by participants
or personnel may have been subject to per-
formance bias
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No blinding of intervention, outcome as-
sessor or data analyser
Incomplete outcome data (attrition bias)
All outcomes
High risk 200 adults were randomised; after 12
months 92 remained in the control group
and 91 in the intervention group. 9 partici-
pants withdrew consent, and 8 were lost to
follow-up. Investigators analysed complete
cases and did not impute missing values
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Selective reporting (reporting bias) Low risk No evidence of selective reporting
Other bias Low risk None noted
Voorend-van Bergen 2015
Methods Study design: 12-month parallel RCT
Setting:multi-centre trial in the Netherlands. Children recruited by their own paediatri-
cian from general hospitals (n = 5) and tertiary referral centres (n = 2) in the Netherlands
from February 2010 to November 2011
Participants Population: 280 participants were randomised to home telemonitoring using ACT
scores (91), to the usual care control group based on ACT without Web feedback (89)
and to a group for which FeNO and the ACT were used to monitor asthma (92). We
chose not to include the FeNO group, as the comparison between Web and control
groups was a purer comparison of the effect of home telemonitoring than of use of FeNO
Baseline characteristics
Mean age (SD): Web 10.6 (2.8), usual care 10.2 (3.2)
% male: Web 66, usual care 69
Inclusion criteria: children aged 4 to 18 years, with atopic asthma based on clinical
symptoms, a previous bronchodilator response of > 9% increase in FEV1 of predicted
(FEV1%) and/or previous airway hyperresponsiveness (AHR) to methacholine. Atopy
was defined as a radioallergosorbent test class 2 or higher for ≥ 1 airborne allergen.
Patients had been using inhaled corticosteroids (ICS) for ≥ 3 months before the start of
the study
Exclusion criteria: active smoking, pulmonary diseases other than asthma, recent (< 1
year) or multiple admissions to an intensive care unit for asthma, inability to perform
FeNO measurements and/or use of omalizumab
Interventions Intervention: In theWeb group, treatment was adapted monthly according to theWeb-
based ACT score filled in online by the children. The researcher or asthma nurse emailed
treatment advice within 3 working days
Control: In the usual care group, treatment was adapted every 4 months according to
the child’s ACT score
In the usual care and Web-based groups, treatment was adapted according to the ACT
score, respectively, at 4-month and 1-month intervals
Outcomes Asthma control on the ACT or the C-ACT; primary endpoint was proportion of symp-
tom-free days (SFD) based on a 4-week Web-based diary filled in at the start and after 1
year. Also measured daily ICS dose. Measured at the start and end of the study; children
seen every 4 months during the 12-month period
Notes Funding: Lung Foundation Netherlands (grant no. 3.4.08.039), the Netherlands Orga-
nization for Health Research (ZonMW) (grant no. 171002101) and Fund Nuts Ohra
(grant no. 0901-023)
Trial registration: NTR 1995
Risk of bias
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Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Children were automatically and ran-
domly allocated to one of the three groups
by a randomisation programme on the
study website, in a 1:1:1 ratio, stratified for
age (<12 or ≥12 years), centre and dose
of ICS (<400 or .400 mg budesonide or
equivalent daily dose; figure 1)”
Allocation concealment (selection bias) Low risk “Automatically and randomly allocated”
suggests that the allocation sequence could
not be tampered with
Blinding of participants and personnel
(performance bias)
Objective outcomes
Low risk It would not have been possible to hide al-
location from participants and personnel,
but it is unlikely that this would have in-
troduced bias for objective outcomes (e.g.
number of people having exacerbations)
Blinding of participants and personnel
(performance bias)
Subjective outcomes
High risk Subjective outcomes such as quality of life
and symptom scales filled in by participants
or personnel may have been subject to per-
formance bias
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Participants were not blinded to randomi-
sation group. Treating physicians were
blinded to randomisation group, FeNO
andACT. Local investigators, unblinded to
ACT and FeNO, provided physicians with
treatment advice based on study algorithms
and on the treatment plan
Incomplete outcome data (attrition bias)
All outcomes
Low risk Total number randomised was 280, and
268 completed the study (95.7%). Loss
to follow-up was low and balanced across
groups
Selective reporting (reporting bias) Low risk Study was prospectively registered, and full
outcome data were available in the pub-
lished paper and in an online supplemen-
tary appendix
Other bias Low risk None noted
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Willems 2008
Methods Study design: 12-month parallel RCT
Setting: single outpatient centre in the Netherlands
Participants Population: 109 outpatients (56 children and 53 adults) were randomised to home
telemonitoring (55) or to control (54)
Baseline characteristics
Mean age (SD): monitoring 27.2 (19.3); control 28.4 (21.0)
% male: monitoring 58.2; control 44.4
Inclusion criteria: asthmatic outpatients from theMedical Respiratory Department and
the Department of Paediatrics. Patients aged 7 and older with an asthma severity of
stage I to III as described in the Global Initiative for Asthma (GINA) guidelines were
potentially eligible. Patients had to be competent to use an asthma monitor, and had to
possess a household phone connection
Exclusion criteria: severe co-morbidity (such as chronic obstructive pulmonary disease
or heart failure), structural defects in the upper airways or lungs
Interventions Intervention: The intervention group used a hand-held electronic asthma monitor con-
nected to the home modem, which registered lung function and symptoms. Participants
were asked to perform daily PEF measurements and to transfer monitor data monthly or
more frequently if symptoms worsened. The asthma nurse classified the asthma follow-
ing a stepwise intervention protocol based on GINA and the Dutch College of General
Practitioners, and guidedmedication changes, usually over the phone. Caregivers assisted
the children in monitor use and in contacts with the asthma nurse
Control: regular outpatient care
Outcomes Primary outcome was asthma-specific quality of life on the AQLQ or the PAQLQ. Chil-
dren aged 12 to 18 years were asked to complete the adolescent version of the ques-
tionnaire by themselves, and parents or caregivers filled in a proxy version for children
aged 7 to 12 years. Secondary outcomes were lung function (PEF and FEV1 at baseline
and endpoint), self reported symptoms on a 0 to 3 scale and asthma-related medical
consumption from diaries (medication use, visits or telephone contacts with health pro-
fessionals and ED visits)
Notes Funding: Dutch Health Care Insurance Board
The paper reported adult and child baseline data separately and together, but reported
efficacy data only for both age groups combined. Study authors were not able to provide
separate efficacy data for adults and children
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomisation took place on participant
level after stratification by age (ages 7 to 18
vs 18 years and older), as regular care dif-
fers between these age groups. The asthma
nurse used a list of random numbers to al-
locate participants to 1 of the 2 treatment
arms
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Allocation concealment (selection bias) Unclear risk No details about whether or how allocation
was concealed
Blinding of participants and personnel
(performance bias)
Objective outcomes
Low risk Participants could not be blinded, and
nurse practitioners were not blinded to al-
location of participants, as they received
monthly transfers of monitor data. It is un-
likely that this would have introduced bias
for objective outcomes (e.g. number of peo-
ple having exacerbations)
Blinding of participants and personnel
(performance bias)
Subjective outcomes
High risk Subjective outcomes such as quality of life
and symptom scales filled in by participants
or personnel may have been subject to per-
formance bias
Blinding of outcome assessment (detection
bias)
All outcomes
High risk We noted no evidence of outcome assessor
blinding
Incomplete outcome data (attrition bias)
All outcomes
High risk 109 participants were randomised, 5 were
lost to follow-up. Technical problems oc-
curred, and when data transfer was missed,
the nurse practitioner attempted to contact
participants by telephone; however this was
not possible in 21% of missed data trans-
fers. At baseline, compliance with filling
in the questionnaires was 100%, for sub-
sequent measurements response rate was
85% to 92% for questionnaires and 81% to
90% for diaries. 28% of PEF data transfers
from adults and 18% from children were
missed
Selective reporting (reporting bias) Low risk Outcomes stated in the Methods were well
reported in the Results, but no trial proto-
col was available to verify
Other bias Low risk None noted
Xu 2010
Methods Study design: 6-month parallel RCT
Setting: recruited from the Royal Children’s Hospital Brisbane, and Caboolture, Gold
Coast, and Ipswich hospitals in Queensland
The trial started in August 2006 and was completed in September 2007
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Participants Population:121participantswere randomised tohome telemonitoring (41) or to control
(41), or to 1 other group not relevant to this review
Baseline characteristics
Mean age (SD): monitoring 6.5 (3); control 7.4 (3)
% male: monitoring 51.2; control 51.2
Inclusion criteria: children and young people aged between 3 and 16 years with doctor-
diagnosed asthma who had had an admission to hospital in the previous 12 months or
had presented at least once in the previous 12 months to an emergency department or
to their general practitioner or specialist with acute asthma requiring oral steroid rescue
Exclusion criteria: NR
Interventions Intervention: The nurse support group received regular follow-up calls from 1 Nurse
Specialist every 2 weeks. When families preferred email contact, the nurse used email to
collect the same data and to offer education and advice on asthma
Control: Participants’ primary care physicians were notified and continued to provide
primary asthma care. All families received the same initial asthma education with the
same Nurse Specialist. The control group received regular GP or hospital outpatient care
Outcomes Primary outcomes were health resource utilisation such as GP visits, hospital ED presen-
tations and hospital admissions. Other outcomes included use of oral steroids, PAQLQ,
time of school or work for parents/carers. Measured at baseline and at the end of the
study
Notes Funding: NR
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Participants were randomised into 3 study
groups. Block randomisationwas usedwith
random block sizes of 3 or 6 to create an
allocation to 1 of the 3 groups for all study
participants
Allocation concealment (selection bias) Unclear risk No details about allocation concealment
Blinding of participants and personnel
(performance bias)
Objective outcomes
Low risk It would not have been possible to hide al-
location from participants and personnel,
but it is unlikely that this would have in-
troduced bias for objective outcomes (e.g.
number of people having exacerbations)
Blinding of participants and personnel
(performance bias)
Subjective outcomes
High risk Subjective outcomes such as quality of life
and symptom scales filled in by participants
or personnel may have been subject to per-
formance bias
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Xu 2010 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No evidence of outcome assessor blinding
Incomplete outcome data (attrition bias)
All outcomes
Low risk One participant in the control group was
lost to follow-up
Selective reporting (reporting bias) Low risk Outcomes were well reported for named
outcomes, but no trial protocol was avail-
able to check
Other bias Low risk None noted
Young 2012
Methods Study design: 3-month parallel RCT
Setting: 11-county region in north central Wisconsin, USA
Participants Population: 98 participants were randomised to home telemonitoring (49) or to control
(49)
Baseline characteristics
Mean age (SD): monitoring 45.4 (16.8); control 43.7 (14)
% male: monitoring 26.5; control 20.4
Inclusion criteria: participation in Community Health Access (a charity programme
sponsored by the Marshfield Clinic and supported by the FHC) or FHC programmes
(federally funded programmes to assist underserved, uninsured and underinsured in-
dividuals in the northern Wisconsin area), 19 years of age or older, English speaking,
receipt of ≥ 1 asthma medication(s) dispensed in the 6-month period ending January
31, 2009, diagnosis of asthma
Exclusion criteria: enrolment in the FHC Pharmacy medication auto-refill programme
Interventions Intervention: telephone consultation from pharmacists regarding asthma self manage-
ment andmedication use. Five pharmacists incorporated the intervention into their usual
practice
Control: usual care, which included mail receipt of a prescription refill with written
medication use instructions
Outcomes AsthmaControl Test, Patient ActivationMeasure, MoriskyMedication Adherence Scale.
Measured at 3-month endpoint and at 6-month follow-up
Notes Funding: Grant 1UL1RR025011 from the Clinical & Translational Science Award
programme of theNational Center for Research Resources, National Institutes of Health
Risk of bias
Bias Authors’ judgement Support for judgement
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Young 2012 (Continued)
Random sequence generation (selection
bias)
Unclear risk Randomised by the data manager. No de-
tails of how the sequence was generated
Allocation concealment (selection bias) Low risk Research assistants then forwarded partici-
pant contact information to a datamanager
for random assignment to the intervention
or control group. Data manager forwarded
intervention groupparticipants’ contact in-
formation to the FHC Pharmacy Manager
for allocation to pharmacists
Blinding of participants and personnel
(performance bias)
Objective outcomes
Low risk It would not have been possible to hide al-
location from participants and personnel,
but it is unlikely that this would have in-
troduced bias for objective outcomes (e.g.
number of people having exacerbations)
Blinding of participants and personnel
(performance bias)
Subjective outcomes
High risk Subjective outcomes such as quality of life
and symptom scales filled in by participants
or personnel may have been subject to per-
formance bias
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Research assistants and researchers were
blinded to allocation of participants to in-
tervention and control groups
Incomplete outcome data (attrition bias)
All outcomes
Low risk Dropout was balanced between groups (~
15% in both groups)
Selective reporting (reporting bias) Low risk No trial registration, but no evidence of se-
lective reporting in the paper
Other bias Low risk None noted
ACT = Asthma Control Test
ACQ = Asthma Control Questionnaire
AQLQ = Asthma Quality of Life Questionnaire
CSQ = Client Satisfaction Questionnaire
ED = emergency department
KASE-AQ = Knowledge, Attitude and Self-efficacy Asthma Questionnaire
NR = not reported
PAQLQ = Paediatric Asthma Quality of Life Questionnaire
PEF = peak expiratory flow
RCT = randomised controlled trial
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Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Aaron 2016 Intervention did not match inclusion criteria - self regulation and goal attainment intervention delivered
over the phone
Andersen 2007 Intervention did not match inclusion criteria - minimal or no provider involvement
Apter 2000 Design did not match inclusion criteria - not a trial report
Apter 2015 Comparison did not match inclusion criteria - telemedicine portal used with or without home visits (both
groups used the portal)
Araujo 2012 Design did not match inclusion criteria - cross-over RCT
Baptist 2013 Comparison did not match inclusion criteria - phone calls for asthma education vs non-asthma education
phone calls
Barbanel 2003 Intervention did not match inclusion criteria - asthma education intervention led by a pharmacist
Bender 2001 Intervention did not match inclusion criteria - study assessing validity of self reports
Bender 2007 Intervention did not match inclusion criteria - study assessing validity of self reports
Bender 2010 Intervention did not match inclusion criteria - minimal or no provider involvement
Boyd 2014 Intervention did not match inclusion criteria - pharmacist-led intervention about adherence
Burbank 2012 Intervention did not match inclusion criteria - focus on asthma education, not on remote monitoring
Burkhart 2002 Intervention did not match inclusion criteria - intervention to improve adherence to home PEF measure-
ments
Bynum 2001 Interventiondidnotmatch inclusion criteria - pharmacy-led technology intervention to improve adherence
Chan 2007 Intervention did not match inclusion criteria - asthma reviews conducted remotely vs face-to-face
Chandler 1990 Intervention did not match inclusion criteria - specifically monitoring theophylline levels
Chatkin 2006 Intervention did not match inclusion criteria - phone calls to promote adherence, not monitoring
Chen 2013 Intervention did not match inclusion criteria - asthma behavioural intervention using technology, not
monitoring
Cicutto 2009 Intervention did not match inclusion criteria - not asthma monitoring with remote feedback
Clark 2007 Intervention did not match inclusion criteria - counselling intervention, not asthma monitoring
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(Continued)
Clarke 2014 Intervention did not match inclusion criteria - parenting intervention, not asthma monitoring
Claus 2004 Design did not match inclusion criteria - not an RCT
Cruz-Correia 2007 Design did not match inclusion criteria - cross-over RCT
de Jongste 2008 Comparison did not match inclusion criteria - comparing 2 types of electronic monitoring (FeNO vs
symptoms)
De Vera 2014 Intervention did not match inclusion criteria - asthma education by a pharmacist, with some adherence
monitoring
Dwinger 2013 Intervention did not match inclusion criteria - coaching/education intervention using technology for
multiple chronic conditions
Eakin 2012 Intervention did not match inclusion criteria - not asthma monitoring with remote feedback
Fonseca 2006 Design did not match inclusion criteria - survey of RCT participants
Foster 2014 Intervention did not match inclusion criteria - intervention to improve adherence, not monitoring
Friedman 1999 Design did not match inclusion criteria - not an RCT report
Garbutt 2010 Intervention did not match inclusion criteria - asthma coaching/education intervention over the phone
Gruffydd-Jones 2005 Intervention did not match inclusion criteria - asthma reviews conducted remotely vs face-to-face
Gustafson 2012 Intervention did not match inclusion criteria - self determination theory intervention, not remote moni-
toring
Halterman 2012 Intervention did not match inclusion criteria - multi-faceted intervention, not just remote monitoring
Hashimoto 2011 Intervention did not match inclusion criteria - steroid tapering remotely vs face-to-face
Huang 2013 Intervention did not match inclusion criteria - support intervention, not remote monitoring
Janevic 2012 Intervention did not match inclusion criteria - management intervention for African American women
Jerant 2003 Intervention did not match inclusion criteria - mixed diagnosis study comparing models for delivering
home care
Kattan 2006 Intervention did not match inclusion criteria - minimal or no provider involvement
Khan 2003 Intervention did not match inclusion criteria - 1 phone call at discharge
Kojima 2005 Intervention did not match inclusion criteria - not technology-based
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(Continued)
Lam 2011 Design did not match inclusion criteria - cross-sectional analysis of an ongoing RCT, and mixed diagnosis
Lobach 2013 Intervention did not match inclusion criteria - not asthma monitoring with remote feedback
MacDonell 2015 Intervention did not match inclusion criteria - focus on improving adherence, not on monitoring
McCowan 2001 Intervention did not match inclusion criteria - computer-aided decision support during consultation
McPherson 2006 Intervention did not match inclusion criteria - asthma education delivered via CD-ROM and book vs
book alone
Merchant 2016 Intervention did not match inclusion criteria - minimal or no provider involvement. Although data could
be made available to patients’ healthcare providers, feedback was provided primarily automatically through
the Propeller Health system and by study researchers
Morrison 2014 Intervention did not match inclusion criteria - minimal or no provider involvement
Murphy 2001 Design did not match inclusion criteria - comment on RCT
NCT00149474 Comparison did not match inclusion criteria - 2 types of remote monitoring (PEF or symptoms)
NCT00562081 Intervention did not match inclusion criteria - focus on asthma education, not on monitoring
NCT00910585 Intervention did not match inclusion criteria - focus on asthma education, not on monitoring
NCT00964301 Intervention did not match inclusion criteria - focus on asthma education, not on monitoring
NCT01117805 Intervention did not match inclusion criteria - counselling intervention, not monitoring
Osman 1997 Intervention did not match inclusion criteria - post-admission follow-up
Pedram 2012 Intervention did not match inclusion criteria - main focus of the study was to educate patients on how to
use a peak flow meter
Peruccio 2005 Intervention did not match inclusion criteria - treatment awareness education delivered over the phone,
not monitoring
Petrie 2012 Intervention did not match inclusion criteria - minimal or no provider involvement
Pinnock 2003 Intervention did not match inclusion criteria - asthma reviews conducted remotely vs face-to-face
Pinnock 2007 Intervention did not match inclusion criteria - asthma reviews conducted remotely vs face-to-face
Price 2007 Intervention did not match inclusion criteria - validating the Asthma Control Test for Internet use
Raat 2007 Design did not match inclusion criteria - questionnaire, not RCT
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(Continued)
Rand 2005 Intervention did not match inclusion criteria - study measuring validity of self report
Rasmussen 2005 Intervention did not match inclusion criteria - asthma reviews conducted remotely vs face-to-face
Rikkers-Mutsaerts 2012 Intervention did not match inclusion criteria - minimal or no provider involvement
Rosenzweig 2008 Intervention did not match inclusion criteria - validation study
Schatz 2003 Comparison did not match inclusion criteria - phone calls on top of face-to-face review
Schatz 2010 Intervention did not match inclusion criteria - letter regarding validation of telephone delivery of the
Asthma Control Questionnaire
Searing 2012 Intervention did not match inclusion criteria - minimal or no provider involvement
Seid 2012 Intervention did not match inclusion criteria - asthma education and motivational interviewing, not
remote monitoring
Shanovich 2009 Intervention did not match inclusion criteria - focus on asthma education, not on remote monitoring
Sparrow 2005 Comparison did not match inclusion criteria - phone monitoring with or without asthma education
Taitel 2014 Intervention did not match inclusion criteria - pharmacy-led compliance intervention, not remote moni-
toring
Uysal 2013 Intervention did not match inclusion criteria - validating the Asthma Control Test via text messaging
van den Berg 2002 Intervention did not match inclusion criteria - GP telephone access to paediatricians
van Gaalen 2012 Intervention did not match inclusion criteria - multi-faceted intervention, not just remote monitoring
van Reisen 2010 Intervention did not match inclusion criteria - multi-faceted intervention, not just remote monitoring
Vasbinder 2013 Intervention did not match inclusion criteria - minimal or no provider involvement. Medication reminder
system
Vollmer 2006 Intervention did not match inclusion criteria - minimal or no provider involvement for most of the
intervention group
Wiecha 2007 Intervention did not match inclusion criteria - multi-faceted intervention, not just remote monitoring
Yun 2013 Intervention did not match inclusion criteria - asthma education via text
Zachgo 2002 Intervention did not match inclusion criteria - computer works out best inhaler type for patient
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(Continued)
Zairina 2015 Intervention did not match inclusion criteria - minimal or no provider involvement. Although data could
be made available to patients’ healthcare providers, feedback was provided primarily automatically or by
study researchers
Characteristics of studies awaiting assessment [ordered by study ID]
Ricci 2001
Methods Unclear whether this is a report of a randomised controlled trial (RCT). Presented as an oral communication - cannot
find additional information to clarify inclusion or exclusion
Participants Children with bronchial asthma, unclear numbers or unclear specific inclusion/exclusion criteria and baseline char-
acteristics
Interventions “A system of teleassistance for in-house monitoring” of respiratory function - no other information about the
intervention or comparison
Outcomes Not available
Notes None
Characteristics of ongoing studies [ordered by study ID]
Ahmed 2011
Trial name or title Facilitating patient self-management in chronic disease: integrating electronic personal health records and
ongoing communication into a web-based self-management tool
Methods Study design: 6-month parallel multi-centre 2-arm pilot randomised controlled trial
Setting: pulmonary clinics in 2 tertiary care hospitals in Montreal, Canada
Participants Population: adults with asthma, full population not yet recruited
Baseline characteristics
Full population not yet recruited, no baseline characteristics
Inclusion criteria: males and females aged 18 to 69 years; physician diagnosis of asthma and prescribed ≥ 1
rescue medication; classified by doctor as having poor asthma control; access to the Internet; smoking < 20
pack-years; can speak and understand English or French
Exclusion criteria: diagnosis of COPD or other serious medical diagnoses (e.g. lung cancer)
Interventions Intervention: My Asthma Portal (MAP) includes tailored education, asthma medical information, tools to
optimise self management and health behaviours and nurse case management support
Control: participants receive ongoing asthma care from a respirologist. An asthma nurse provides education
and follow-up as needed. Topics such as the importance of avoiding triggers, taking all asthma medications
as prescribed and using the written action plan as needed. Follow-up phone calls between visits are provided
by the asthma nurse, when appropriate (i.e. missed appointments, to clarify aspects of the action plan or
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Ahmed 2011 (Continued)
prescribed asthma medications)
Outcomes Primary outcomes are asthma control and asthma health-related quality of life. Secondary outcomes are
acceptance of the technology, usage rates, pattern usage, asthma self efficacy, medication adherence and
healthcare utilisation
Starting date 30/03/2009
Contact information Professor Sarah Ahmed
3654 Prom Sir-William-Osler
Montreal
H3G 1Y5
Canada
+1 514 398 4400 ext. 00531
Notes Funding : Canadian Institutes of Health Research
ID number(s): ISRCTN34326236
Perry 2015
Trial name or title Breath connection: a school-based telemedicine program for rural children with asthma
Methods Cluster-randomised trial
Participants Rural children, ages 7 to 14 years
Interventions Comparing a school-based telemedicine intervention against usual care. The intervention provides compre-
hensive asthma education via telemedicine to rural children with asthma, their caregivers and school nurses;
prospectively monitors asthma symptoms and lung function; and provides primary care providers with evi-
dence-based treatment prompts
Outcomes Days wheezing, peak flow meter use, symptom-free days
Starting date Unclear
Contact information University of Arkansas for Medical Sciences, Little Rock, AR
Notes To date, 364/414 parent-child dyads have been enrolled from 17 school districts in the rural Mississippi
Delta region of Arkansas. Median age of children enrolled is 9.6 years, with 54.6% male, 81.8% African
American, 80% with state-issued insurance and 45.6% from a family with total household income < $15,
000. At baseline, 72.2% of children were classified as patients with moderate to severe persistent asthma, and
72.1% had uncontrolled asthma according to national guidelines
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D A T A A N D A N A L Y S E S
Comparison 1. Home telemonitoring with feedback vs usual monitoring
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Exacerbations requiring oral
corticosteroids (subgrouped by
age)
4 466 Odds Ratio (M-H, Random, 95% CI) 0.93 [0.60, 1.44]
1.1 Children (< 16 years) 2 125 Odds Ratio (M-H, Random, 95% CI) 1.02 [0.46, 2.29]
1.2 Adults (17 to 65 years) 2 341 Odds Ratio (M-H, Random, 95% CI) 0.90 [0.54, 1.50]
2 Exacerbations requiring ED visit
(subgrouped by age)
8 1018 Odds Ratio (M-H, Random, 95% CI) 0.75 [0.36, 1.58]
2.1 Children (< 16 years) 2 201 Odds Ratio (M-H, Random, 95% CI) 0.90 [0.24, 3.30]
2.2 Adults (17 to 65 years) 6 817 Odds Ratio (M-H, Random, 95% CI) 0.66 [0.23, 1.91]
3 Exacerbations requiring hospital
admission (subgrouped by age)
10 1042 Odds Ratio (M-H, Random, 95% CI) 0.56 [0.21, 1.49]
3.1 Children (< 16 years) 4 421 Odds Ratio (M-H, Random, 95% CI) 1.38 [0.51, 3.68]
3.2 Adults (17 to 65 years) 6 621 Odds Ratio (M-H, Random, 95% CI) 0.24 [0.06, 0.94]
4 Asthma control (ACQ) 2 478 Mean Difference (IV, Random, 95% CI) -0.24 [-0.72, 0.24]
5 Asthma control (ACT) 1 Mean Difference (Random, 95% CI) 0.09 [-0.92, 1.10]
6 ACT > 19 (well controlled) 1 Odds Ratio (M-H, Random, 95% CI) Totals not selected
7 Asthma-related quality of life
(AQLQ)
6 796 Mean Difference (Random, 95% CI) 0.23 [0.01, 0.45]
8 Lung function (trough FEV1) 3 149 Mean Difference (IV, Random, 95% CI) 7.21 [1.52, 12.89]
9 Lung function (change in PEF
L/min)
1 66 Mean Difference (IV, Random, 95% CI) 13.20 [0.58, 25.82]
10 Unscheduled healthcare visits 3 430 Odds Ratio (M-H, Random, 95% CI) 0.99 [0.37, 2.62]
Comparison 2. Type of technology subgroups
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Exacerbations requiring oral
corticosteroids
4 466 Odds Ratio (M-H, Random, 95% CI) 0.93 [0.60, 1.44]
1.1 Phone calls 2 141 Odds Ratio (M-H, Random, 95% CI) 0.94 [0.48, 1.88]
1.2 Web system 1 44 Odds Ratio (M-H, Random, 95% CI) 0.90 [0.12, 7.07]
1.3 Smartphone app 1 281 Odds Ratio (M-H, Random, 95% CI) 0.93 [0.52, 1.65]
2 Exacerbations requiring ED visit 8 1018 Odds Ratio (M-H, Random, 95% CI) 0.75 [0.36, 1.58]
2.1 Phone calls 2 150 Odds Ratio (M-H, Random, 95% CI) 1.62 [0.68, 3.89]
2.2 Web system 3 376 Odds Ratio (M-H, Random, 95% CI) 0.59 [0.15, 2.35]
2.3 Smartphone app 2 370 Odds Ratio (M-H, Random, 95% CI) 0.81 [0.02, 40.79]
2.4 Portable device 1 122 Odds Ratio (M-H, Random, 95% CI) 0.48 [0.16, 1.39]
3 Exacerbations requiring hospital
admission
10 1042 Odds Ratio (M-H, Random, 95% CI) 0.56 [0.21, 1.49]
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3.1 Phone calls 2 138 Odds Ratio (M-H, Random, 95% CI) 0.43 [0.05, 3.43]
3.2 Web system 4 396 Odds Ratio (M-H, Random, 95% CI) 0.42 [0.10, 1.82]
3.3 Smartphone app 2 370 Odds Ratio (M-H, Random, 95% CI) 1.41 [0.18, 10.89]
3.4 Portable device 1 122 Odds Ratio (M-H, Random, 95% CI) 4.07 [0.44, 37.50]
3.5 SMS 1 16 Odds Ratio (M-H, Random, 95% CI) 0.05 [0.00, 0.66]
Analysis 1.1. Comparison 1 Home telemonitoring with feedback vs usual monitoring, Outcome 1
Exacerbations requiring oral corticosteroids (subgrouped by age).
Review: Home telemonitoring and remote feedback between clinic visits for asthma
Comparison: 1 Home telemonitoring with feedback vs usual monitoring
Outcome: 1 Exacerbations requiring oral corticosteroids (subgrouped by age)
Study or subgroup
Telemonitoring
+ feedback Usual monitoring Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Children (< 16 years)
Deschildre 2012 19/21 21/23 4.4 % 0.90 [ 0.12, 7.07 ]
Xu 2010 22/41 21/40 24.5 % 1.05 [ 0.44, 2.51 ]
Subtotal (95% CI) 62 63 28.9 % 1.02 [ 0.46, 2.29 ]
Total events: 41 (Telemonitoring + feedback), 42 (Usual monitoring)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.02, df = 1 (P = 0.90); I2 =0.0%
Test for overall effect: Z = 0.06 (P = 0.95)
2 Adults (17 to 65 years)
Donald 2008 (1) 21/31 21/29 15.2 % 0.80 [ 0.26, 2.43 ]
Ryan 2012 28/140 30/141 55.9 % 0.93 [ 0.52, 1.65 ]
Subtotal (95% CI) 171 170 71.1 % 0.90 [ 0.54, 1.50 ]
Total events: 49 (Telemonitoring + feedback), 51 (Usual monitoring)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.05, df = 1 (P = 0.82); I2 =0.0%
Test for overall effect: Z = 0.42 (P = 0.68)
Total (95% CI) 233 233 100.0 % 0.93 [ 0.60, 1.44 ]
Total events: 90 (Telemonitoring + feedback), 93 (Usual monitoring)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.14, df = 3 (P = 0.99); I2 =0.0%
Test for overall effect: Z = 0.32 (P = 0.75)
Test for subgroup differences: Chi2 = 0.07, df = 1 (P = 0.78), I2 =0.0%
0.5 0.7 1 1.5 2
Favours telemonitoring Favours usual monitoring
(1) Number of people per group starting or increasing OCS
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Analysis 1.2. Comparison 1 Home telemonitoring with feedback vs usual monitoring, Outcome 2
Exacerbations requiring ED visit (subgrouped by age).
Review: Home telemonitoring and remote feedback between clinic visits for asthma
Comparison: 1 Home telemonitoring with feedback vs usual monitoring
Outcome: 2 Exacerbations requiring ED visit (subgrouped by age)
Study or subgroup
Telemonitoring
+ feedback Usual monitoring Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Children (< 16 years)
Guendelman 2002 6/62 11/60 18.6 % 0.48 [ 0.16, 1.39 ]
Xu 2010 8/39 5/40 16.6 % 1.81 [ 0.53, 6.10 ]
Subtotal (95% CI) 101 100 35.2 % 0.90 [ 0.24, 3.30 ]
Total events: 14 (Telemonitoring + feedback), 16 (Usual monitoring)
Heterogeneity: Tau2 = 0.54; Chi2 = 2.60, df = 1 (P = 0.11); I2 =62%
Test for overall effect: Z = 0.16 (P = 0.87)
2 Adults (17 to 65 years)
Donald 2008 7/36 5/35 16.2 % 1.45 [ 0.41, 5.09 ]
Kokubu 2000 32/33 34/34 4.5 % 0.31 [ 0.01, 7.99 ]
Liu 2011 2/43 12/46 12.9 % 0.14 [ 0.03, 0.66 ]
Ryan 2012 3/140 0/141 5.2 % 7.20 [ 0.37, 140.76 ]
van der Meer 2009 11/101 10/99 20.8 % 1.09 [ 0.44, 2.69 ]
Willems 2008 (1) 0/55 4/54 5.3 % 0.10 [ 0.01, 1.92 ]
Subtotal (95% CI) 408 409 64.8 % 0.66 [ 0.23, 1.91 ]
Total events: 55 (Telemonitoring + feedback), 65 (Usual monitoring)
Heterogeneity: Tau2 = 0.81; Chi2 = 10.56, df = 5 (P = 0.06); I2 =53%
Test for overall effect: Z = 0.77 (P = 0.44)
Total (95% CI) 509 509 100.0 % 0.75 [ 0.36, 1.58 ]
Total events: 69 (Telemonitoring + feedback), 81 (Usual monitoring)
Heterogeneity: Tau2 = 0.48; Chi2 = 13.16, df = 7 (P = 0.07); I2 =47%
Test for overall effect: Z = 0.76 (P = 0.45)
Test for subgroup differences: Chi2 = 0.13, df = 1 (P = 0.72), I2 =0.0%
0.005 0.1 1 10 200
Favours telemonitoring Favours usual monitoring
(1) This study recruited roughly equal numbers of adults and children. The mean age was 27 and data were not available for adults and children separately.
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Analysis 1.3. Comparison 1 Home telemonitoring with feedback vs usual monitoring, Outcome 3
Exacerbations requiring hospital admission (subgrouped by age).
Review: Home telemonitoring and remote feedback between clinic visits for asthma
Comparison: 1 Home telemonitoring with feedback vs usual monitoring
Outcome: 3 Exacerbations requiring hospital admission (subgrouped by age)
Study or subgroup
Telemonitoring
+ feedback Usual monitoring Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Children (< 16 years)
Deschildre 2012 2/21 2/23 12.0 % 1.11 [ 0.14, 8.64 ]
Guendelman 2002 4/62 1/60 11.0 % 4.07 [ 0.44, 37.50 ]
Voorend-van Bergen 2015 1/90 1/87 8.3 % 0.97 [ 0.06, 15.69 ]
Xu 2010 4/38 4/40 16.2 % 1.06 [ 0.25, 4.57 ]
Subtotal (95% CI) 211 210 47.4 % 1.38 [ 0.51, 3.68 ]
Total events: 11 (Telemonitoring + feedback), 8 (Usual monitoring)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.16, df = 3 (P = 0.76); I2 =0.0%
Test for overall effect: Z = 0.64 (P = 0.52)
2 Adults (17 to 65 years)
Donald 2008 1/31 6/29 11.2 % 0.13 [ 0.01, 1.14 ]
Kokubu 2000 2/32 11/34 15.1 % 0.14 [ 0.03, 0.69 ]
Liu 2011 0/43 1/46 6.7 % 0.35 [ 0.01, 8.79 ]
Ostojic 2005 2/8 7/8 8.9 % 0.05 [ 0.00, 0.66 ]
Ryan 2012 3/140 1/141 10.7 % 3.07 [ 0.32, 29.83 ]
Willems 2008 (1) 0/55 0/54 Not estimable
Subtotal (95% CI) 309 312 52.6 % 0.24 [ 0.06, 0.94 ]
Total events: 8 (Telemonitoring + feedback), 26 (Usual monitoring)
Heterogeneity: Tau2 = 1.04; Chi2 = 7.09, df = 4 (P = 0.13); I2 =44%
Test for overall effect: Z = 2.05 (P = 0.041)
Total (95% CI) 520 522 100.0 % 0.56 [ 0.21, 1.49 ]
Total events: 19 (Telemonitoring + feedback), 34 (Usual monitoring)
Heterogeneity: Tau2 = 0.97; Chi2 = 14.62, df = 8 (P = 0.07); I2 =45%
Test for overall effect: Z = 1.16 (P = 0.25)
Test for subgroup differences: Chi2 = 4.13, df = 1 (P = 0.04), I2 =76%
0.01 0.1 1 10 100
Favours telemonitoring Favours usual monitoring
(1) This study recruited roughly equal numbers of adults and children. The mean age was 27 and data were not available for adults and children separately.
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Analysis 1.4. Comparison 1 Home telemonitoring with feedback vs usual monitoring, Outcome 4 Asthma
control (ACQ).
Review: Home telemonitoring and remote feedback between clinic visits for asthma
Comparison: 1 Home telemonitoring with feedback vs usual monitoring
Outcome: 4 Asthma control (ACQ)
Study or subgroup
Telemonitoring
+ feedback Usual monitoring
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Ryan 2012 (1) 139 1.57 (0.99) 139 1.56 (1.09) 48.2 % 0.01 [ -0.23, 0.25 ]
van der Meer 2009 (2) 101 -0.54 (0.5572) 99 -0.06 (0.6017) 51.8 % -0.48 [ -0.64, -0.32 ]
Total (95% CI) 240 238 100.0 % -0.24 [ -0.72, 0.24 ]
Heterogeneity: Tau2 = 0.11; Chi2 = 10.75, df = 1 (P = 0.001); I2 =91%
Test for overall effect: Z = 1.00 (P = 0.32)
Test for subgroup differences: Not applicable
-1 -0.5 0 0.5 1
Favours telemonitoring Favours usual monitoring
(1) adult study
(2) adult study
Analysis 1.5. Comparison 1 Home telemonitoring with feedback vs usual monitoring, Outcome 5 Asthma
control (ACT).
Review: Home telemonitoring and remote feedback between clinic visits for asthma
Comparison: 1 Home telemonitoring with feedback vs usual monitoring
Outcome: 5 Asthma control (ACT)
Study or subgroup Mean Difference (SE)
Mean
Difference Weight
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Voorend-van Bergen 2015 (1) 0.09 (0.5153) 100.0 % 0.09 [ -0.92, 1.10 ]
Total (95% CI) 100.0 % 0.09 [ -0.92, 1.10 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.17 (P = 0.86)
Test for subgroup differences: Not applicable
-10 -5 0 5 10
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(1) Child study
Analysis 1.6. Comparison 1 Home telemonitoring with feedback vs usual monitoring, Outcome 6 ACT > 19
(well controlled).
Review: Home telemonitoring and remote feedback between clinic visits for asthma
Comparison: 1 Home telemonitoring with feedback vs usual monitoring
Outcome: 6 ACT > 19 (well controlled)
Study or subgroup
Telemonitoring
+ feedback Usual monitoring Odds Ratio Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Cingi 2015 (1) 29/60 8/29 2.46 [ 0.94, 6.41 ]
0.01 0.1 1 10 100
Favours usual monitoring Favours telemonitoring
(1) Adult study
71Home telemonitoring and remote feedback between clinic visits for asthma (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.7. Comparison 1 Home telemonitoring with feedback vs usual monitoring, Outcome 7 Asthma-
related quality of life (AQLQ).
Review: Home telemonitoring and remote feedback between clinic visits for asthma
Comparison: 1 Home telemonitoring with feedback vs usual monitoring
Outcome: 7 Asthma-related quality of life (AQLQ)
Study or subgroup
Telemonitoring
+ feedback Usual monitoring Mean Difference (SE)
Mean
Difference Weight
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
Deschildre 2012 21 23 0.12 (0.7201) 2.3 % 0.12 [ -1.29, 1.53 ]
Ryan 2012 97 104 0.01 (0.1877) 17.8 % 0.01 [ -0.36, 0.38 ]
van der Meer 2009 91 92 0.32 (0.1013) 27.1 % 0.32 [ 0.12, 0.52 ]
Voorend-van Bergen 2015 90 87 -0.05 (0.148) 21.8 % -0.05 [ -0.34, 0.24 ]
Willems 2008 55 54 0.25 (0.2177) 15.2 % 0.25 [ -0.18, 0.68 ]
Xu 2010 41 41 0.7 (0.2101) 15.8 % 0.70 [ 0.29, 1.11 ]
Total (95% CI) 395 401 100.0 % 0.23 [ 0.01, 0.45 ]
Heterogeneity: Tau2 = 0.04; Chi2 = 10.78, df = 5 (P = 0.06); I2 =54%
Test for overall effect: Z = 2.02 (P = 0.043)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
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Analysis 1.8. Comparison 1 Home telemonitoring with feedback vs usual monitoring, Outcome 8 Lung
function (trough FEV1).
Review: Home telemonitoring and remote feedback between clinic visits for asthma
Comparison: 1 Home telemonitoring with feedback vs usual monitoring
Outcome: 8 Lung function (trough FEV1)
Study or subgroup
Telemonitoring
+ feedback Usual monitoring
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Deschildre 2012 (1) 21 95.3 (12.3) 23 88.8 (16.4) 44.5 % 6.50 [ -2.02, 15.02 ]
Liu 2011 (2) 43 65.2 (20.9838) 46 56.5 (18.9905) 46.5 % 8.70 [ 0.37, 17.03 ]
Ostojic 2005 (3) 8 81.25 (17.31) 8 78.25 (21.09) 9.0 % 3.00 [ -15.91, 21.91 ]
Total (95% CI) 72 77 100.0 % 7.21 [ 1.52, 12.89 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.34, df = 2 (P = 0.84); I2 =0.0%
Test for overall effect: Z = 2.49 (P = 0.013)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
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(1) Pre-bronchodilator % predicted. Data provided by study authors.
(2) % predicted
(3) % predicted
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Analysis 1.9. Comparison 1 Home telemonitoring with feedback vs usual monitoring, Outcome 9 Lung
function (change in PEF L/min).
Review: Home telemonitoring and remote feedback between clinic visits for asthma
Comparison: 1 Home telemonitoring with feedback vs usual monitoring
Outcome: 9 Lung function (change in PEF L/min)
Study or subgroup
Telemonitoring
+ feedback Usual monitoring
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Kokubu 2000 32 13.4 (27.6) 34 0.2 (24.5) 100.0 % 13.20 [ 0.58, 25.82 ]
Total (95% CI) 32 34 100.0 % 13.20 [ 0.58, 25.82 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.05 (P = 0.040)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours usual monitoring Favours telemonitoring
Analysis 1.10. Comparison 1 Home telemonitoring with feedback vs usual monitoring, Outcome 10
Unscheduled healthcare visits.
Review: Home telemonitoring and remote feedback between clinic visits for asthma
Comparison: 1 Home telemonitoring with feedback vs usual monitoring
Outcome: 10 Unscheduled healthcare visits
Study or subgroup
Telemonitoring
+ feedback Usual monitoring Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Cingi 2015 7/60 9/29 28.9 % 0.29 [ 0.10, 0.89 ]
Donald 2008 22/31 16/29 29.8 % 1.99 [ 0.68, 5.77 ]
Ryan 2012 51/140 41/141 41.3 % 1.40 [ 0.85, 2.31 ]
Total (95% CI) 231 199 100.0 % 0.99 [ 0.37, 2.62 ]
Total events: 80 (Telemonitoring + feedback), 66 (Usual monitoring)
Heterogeneity: Tau2 = 0.53; Chi2 = 7.35, df = 2 (P = 0.03); I2 =73%
Test for overall effect: Z = 0.02 (P = 0.98)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours telemonitoring Favours usual monitoring
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Analysis 2.1. Comparison 2 Type of technology subgroups, Outcome 1 Exacerbations requiring oral
corticosteroids.
Review: Home telemonitoring and remote feedback between clinic visits for asthma
Comparison: 2 Type of technology subgroups
Outcome: 1 Exacerbations requiring oral corticosteroids
Study or subgroup
Telemonitoring
+ feedback Usual monitoring Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Phone calls
Donald 2008 (1) 21/31 21/29 15.2 % 0.80 [ 0.26, 2.43 ]
Xu 2010 (2) 22/41 21/40 24.5 % 1.05 [ 0.44, 2.51 ]
Subtotal (95% CI) 72 69 39.7 % 0.94 [ 0.48, 1.88 ]
Total events: 43 (Telemonitoring + feedback), 42 (Usual monitoring)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.14, df = 1 (P = 0.71); I2 =0.0%
Test for overall effect: Z = 0.16 (P = 0.87)
2 Web system
Deschildre 2012 19/21 21/23 4.4 % 0.90 [ 0.12, 7.07 ]
Subtotal (95% CI) 21 23 4.4 % 0.90 [ 0.12, 7.07 ]
Total events: 19 (Telemonitoring + feedback), 21 (Usual monitoring)
Heterogeneity: not applicable
Test for overall effect: Z = 0.10 (P = 0.92)
3 Smartphone app
Ryan 2012 28/140 30/141 55.9 % 0.93 [ 0.52, 1.65 ]
Subtotal (95% CI) 140 141 55.9 % 0.93 [ 0.52, 1.65 ]
Total events: 28 (Telemonitoring + feedback), 30 (Usual monitoring)
Heterogeneity: not applicable
Test for overall effect: Z = 0.26 (P = 0.79)
Total (95% CI) 233 233 100.0 % 0.93 [ 0.60, 1.44 ]
Total events: 90 (Telemonitoring + feedback), 93 (Usual monitoring)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.14, df = 3 (P = 0.99); I2 =0.0%
Test for overall effect: Z = 0.32 (P = 0.75)
Test for subgroup differences: Chi2 = 0.00, df = 2 (P = 1.00), I2 =0.0%
0.01 0.1 1 10 100
Favours telemonitoring Favours usual monitoring
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(1) Number of people per group starting or increasing OCS
(2) In this study, nurses could also communicate with participants via email
Analysis 2.2. Comparison 2 Type of technology subgroups, Outcome 2 Exacerbations requiring ED visit.
Review: Home telemonitoring and remote feedback between clinic visits for asthma
Comparison: 2 Type of technology subgroups
Outcome: 2 Exacerbations requiring ED visit
Study or subgroup
Telemonitoring
+ feedback Usual monitoring Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Phone calls
Donald 2008 7/36 5/35 16.2 % 1.45 [ 0.41, 5.09 ]
Xu 2010 (1) 8/39 5/40 16.6 % 1.81 [ 0.53, 6.10 ]
Subtotal (95% CI) 75 75 32.8 % 1.62 [ 0.68, 3.89 ]
Total events: 15 (Telemonitoring + feedback), 10 (Usual monitoring)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.06, df = 1 (P = 0.80); I2 =0.0%
Test for overall effect: Z = 1.09 (P = 0.28)
2 Web system
Kokubu 2000 32/33 34/34 4.5 % 0.31 [ 0.01, 7.99 ]
van der Meer 2009 11/101 10/99 20.8 % 1.09 [ 0.44, 2.69 ]
Willems 2008 (2) 0/55 4/54 5.3 % 0.10 [ 0.01, 1.92 ]
Subtotal (95% CI) 189 187 30.5 % 0.59 [ 0.15, 2.35 ]
Total events: 43 (Telemonitoring + feedback), 48 (Usual monitoring)
Heterogeneity: Tau2 = 0.53; Chi2 = 2.77, df = 2 (P = 0.25); I2 =28%
Test for overall effect: Z = 0.75 (P = 0.45)
3 Smartphone app
Liu 2011 2/43 12/46 12.9 % 0.14 [ 0.03, 0.66 ]
Ryan 2012 3/140 0/141 5.2 % 7.20 [ 0.37, 140.76 ]
Subtotal (95% CI) 183 187 18.1 % 0.81 [ 0.02, 40.79 ]
Total events: 5 (Telemonitoring + feedback), 12 (Usual monitoring)
Heterogeneity: Tau2 = 6.59; Chi2 = 5.49, df = 1 (P = 0.02); I2 =82%
Test for overall effect: Z = 0.10 (P = 0.92)
4 Portable device
Guendelman 2002 6/62 11/60 18.6 % 0.48 [ 0.16, 1.39 ]
0.005 0.1 1 10 200
Favours Telemonitoring + feedback Favours usual monitoring
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(. . . Continued)
Study or subgroup
Telemonitoring
+ feedback Usual monitoring Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Subtotal (95% CI) 62 60 18.6 % 0.48 [ 0.16, 1.39 ]
Total events: 6 (Telemonitoring + feedback), 11 (Usual monitoring)
Heterogeneity: not applicable
Test for overall effect: Z = 1.36 (P = 0.17)
Total (95% CI) 509 509 100.0 % 0.75 [ 0.36, 1.58 ]
Total events: 69 (Telemonitoring + feedback), 81 (Usual monitoring)
Heterogeneity: Tau2 = 0.48; Chi2 = 13.16, df = 7 (P = 0.07); I2 =47%
Test for overall effect: Z = 0.76 (P = 0.45)
Test for subgroup differences: Chi2 = 3.47, df = 3 (P = 0.32), I2 =14%
0.005 0.1 1 10 200
Favours Telemonitoring + feedback Favours usual monitoring
(1) In this study, nurses could also communicate with participants via email
(2) This study recruited roughly equal numbers of adults and children. The mean age was 27 and data were not available for adults and children separately.
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Analysis 2.3. Comparison 2 Type of technology subgroups, Outcome 3 Exacerbations requiring hospital
admission.
Review: Home telemonitoring and remote feedback between clinic visits for asthma
Comparison: 2 Type of technology subgroups
Outcome: 3 Exacerbations requiring hospital admission
Study or subgroup
Telemonitoring
+ feedback Usual monitoring Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Phone calls
Donald 2008 1/31 6/29 11.2 % 0.13 [ 0.01, 1.14 ]
Xu 2010 4/38 4/40 16.2 % 1.06 [ 0.25, 4.57 ]
Subtotal (95% CI) 69 69 27.4 % 0.43 [ 0.05, 3.43 ]
Total events: 5 (Telemonitoring + feedback), 10 (Usual monitoring)
Heterogeneity: Tau2 = 1.39; Chi2 = 2.55, df = 1 (P = 0.11); I2 =61%
Test for overall effect: Z = 0.80 (P = 0.43)
2 Web system
Deschildre 2012 2/21 2/23 12.0 % 1.11 [ 0.14, 8.64 ]
Kokubu 2000 2/32 11/34 15.1 % 0.14 [ 0.03, 0.69 ]
Voorend-van Bergen 2015 1/90 1/87 8.3 % 0.97 [ 0.06, 15.69 ]
Willems 2008 (1) 0/55 0/54 Not estimable
Subtotal (95% CI) 198 198 35.3 % 0.42 [ 0.10, 1.82 ]
Total events: 5 (Telemonitoring + feedback), 14 (Usual monitoring)
Heterogeneity: Tau2 = 0.57; Chi2 = 3.00, df = 2 (P = 0.22); I2 =33%
Test for overall effect: Z = 1.16 (P = 0.25)
3 Smartphone app
Liu 2011 0/43 1/46 6.7 % 0.35 [ 0.01, 8.79 ]
Ryan 2012 3/140 1/141 10.7 % 3.07 [ 0.32, 29.83 ]
Subtotal (95% CI) 183 187 17.4 % 1.41 [ 0.18, 10.89 ]
Total events: 3 (Telemonitoring + feedback), 2 (Usual monitoring)
Heterogeneity: Tau2 = 0.34; Chi2 = 1.17, df = 1 (P = 0.28); I2 =14%
Test for overall effect: Z = 0.33 (P = 0.74)
4 Portable device
Guendelman 2002 4/62 1/60 11.0 % 4.07 [ 0.44, 37.50 ]
Subtotal (95% CI) 62 60 11.0 % 4.07 [ 0.44, 37.50 ]
Total events: 4 (Telemonitoring + feedback), 1 (Usual monitoring)
Heterogeneity: not applicable
Test for overall effect: Z = 1.24 (P = 0.22)
5 SMS
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(. . . Continued)
Study or subgroup
Telemonitoring
+ feedback Usual monitoring Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Ostojic 2005 2/8 7/8 8.9 % 0.05 [ 0.00, 0.66 ]
Subtotal (95% CI) 8 8 8.9 % 0.05 [ 0.00, 0.66 ]
Total events: 2 (Telemonitoring + feedback), 7 (Usual monitoring)
Heterogeneity: not applicable
Test for overall effect: Z = 2.26 (P = 0.024)
Total (95% CI) 520 522 100.0 % 0.56 [ 0.21, 1.49 ]
Total events: 19 (Telemonitoring + feedback), 34 (Usual monitoring)
Heterogeneity: Tau2 = 0.97; Chi2 = 14.62, df = 8 (P = 0.07); I2 =45%
Test for overall effect: Z = 1.16 (P = 0.25)
Test for subgroup differences: Chi2 = 7.40, df = 4 (P = 0.12), I2 =46%
0.01 0.1 1 10 100
Favours telemonitoring Favours usual monitoring
(1) This study recruited roughly equal numbers of adults and children. The mean age was 27 and data were not available for adults and children separately.
A D D I T I O N A L T A B L E S
Table 1. Summary of study and intervention characteristics
Study ID N Country Duration
(mo)
Age group Mean age
(y)
% male Technology Interven-
tion
Control
Bateman
2000
135 South
Africa
12 Adults NR NR Web system Interactive
Web system.
Daily mo-
dem transfer
of spirome-
try data, clin-
ician
decision sup-
port and par-
ticipant edu-
cation
Usual care,
no addi-
tional moni-
toring
Cingi
2015
136 Turkey 3 Adults 32.8 47.2 Smartphone
app
Mobile
phone appli-
cation
(POPET-
Asthma)
to commu-
nicate with
Usual
care. Mobile
phone app to
record symp-
toms at be-
ginning and
end only. No
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Table 1. Summary of study and intervention characteristics (Continued)
their physi-
cian, record
health status
and medica-
tion compli-
ance
feedback
Deschildre
2012
50 France 12 Children 11.1* 74.0 Web system Interactive
Web system.
Daily mo-
dem transfer
of spirome-
try data with
treatment
feedback
from physi-
cian
Usual care,
no addi-
tional moni-
toring
Donald
2008
71 Australia 12 Adults 36.2 23.9 Phone calls Six phone
calls from
the nurse to
monitor
symptoms
and give ad-
vice. All re-
ceived a PEF
meter, edu-
ca-
tion session
and AAP
Usual care
plus
an education
session, PEF
meter and
AAP
Finkelstein
2005
240 USA 12 Adults NR NR Portable de-
vice
Portable
computer
connected to
home
PEFmeter to
monitor
symptoms
and commu-
nicate with
practitioner
Usual care,
no addi-
tional moni-
toring
Guendel-
man
2002
134 USA 3 Children 12.1 57.5 Portable de-
vice
Interac-
tive ’Health
Buddy’ de-
vice for edu-
cation
and manage-
ment. PEF,
Paper
asthma diary
with 2 fol-
low-up visits
with nurse
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Table 1. Summary of study and intervention characteristics (Continued)
symptom
and medica-
tion
responses re-
viewed daily
by nurse
Jan 2007 164 Taiwan 3 Children 10.4 38.4 Web system
and phone
Inter-
net symptom
and PEF di-
aries and in-
di-
vidual AAP
that could be
shared with
physician,
who
provided
feedback
via phone or
email
Usual care
with asthma
education,
PEF meter
and AAP
Kokubu
1999
50 Japan 6 Adults 52.8 46.0 Web system
Telemedicine
system to
monitor
airway status
at home
with nurse
instruction
via phone
Usual care,
no addi-
tional moni-
toring
Kokubu
2000
75 Japan 6 Adults 48.6 36.0 Web system
Telemedicine
system to
monitor
airway status
at home
with nurse
instruction
via phone
Usual care,
no addi-
tional moni-
toring
Liu 2011 120 Taiwan 6 Adults 52.2 49.5 Smartphone
app
Mo-
bile phone-
based soft-
ware with
online symp-
tom, medi-
cation and
Written
asthma diary
and AAP
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Table 1. Summary of study and intervention characteristics (Continued)
lung func-
tion diary re-
viewed by
medical staff
Ostojic
2005
16 Croatia 4 Adults/
teens
24.7 56.5 SMS PEF, symp-
toms
and medica-
tion use sent
via SMS to
asthma spe-
cialist, who
gave weekly
SMS advice
for review or
medications
PEF, symp-
toms
and medica-
tion use di-
ary reviewed
at the end of
the study
Prab-
hakaran
2009
120 Singapore 3 Adults 38.5 41.0 SMS SMS moni-
toring with
advice on
asthma con-
trol
Usual care,
no addi-
tional moni-
toring
Ryan 2012 288 UK 6 Adults/
teens
49.0 37.6 Smartphone
app
Symptom,
PEF and
medication
data sent via
mobile
phone twice
daily with
immedi-
ate feedback
according to
AAP
Paper-
based mon-
itoring with
same guide-
line-based
care as the
active group
van der
Meer 2009
200 Nether-
lands
12 Adults 36.5 30.5 Web system
or SMS
Daily FEV1,
weekly ACQ
and symp-
tom report-
ing via SMS
or a website,
which
also held ed-
ucation and
a treatment
plan
Access to di-
ary
online - not
transmitted
Voorend-
van Bergen
2015
180 Nether-
lands
12 Children 10.4 66.0 Web system Web-based
monthly
Usual care,
no addi-
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Table 1. Summary of study and intervention characteristics (Continued)
monitoring
of
asthma con-
trol accord-
ing to scores
on the ACT
tional moni-
toring
Willems
2008
109 Nether-
lands
12 Adults/
children
27.8 51.4 Web system Asthma
monitor
with home
modem
transferring
symptoms
and medica-
tion use di-
aries to an
asthma nurse
Usual care,
no addi-
tional moni-
toring
Xu 2010 82 Australia 6 Children 7.0 51.2 Phone calls
or emails
Fort-
nightly calls
or emails
from a nurse
specialist to
collect symp-
tom data and
to offer ed-
ucation and
advice
Usual
care plus ed-
ucation ses-
sion
Young
2012
98 USA 3 Adults 44.5 23.5 Phone calls Phone
call with the
phar-
macist to as-
sess self man-
agement and
medication
usage
Usual
care includ-
ing mail re-
ceipt of pre-
scription re-
fill and writ-
ten instruc-
tions
N is the total number of participants randomised to the intervention and control group(s) relevant to this review
% FEV1 is the baseline mean of predicted normal values
AAP = asthma action plan
ACQ = Asthma Control Questionnaire
ACT = Asthma Control Test
FEV1 = forced expiratory volume in one second
mo = months
NR = not reported
PEF = peak expiratory flow
POPET = Physician On Call Patient Engagement Trial
SMS = short message service
y = years
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*Value is the mean of the median ages reported for the intervention and control groups in Deschildre 2012
A P P E N D I C E S
Appendix 1. Sources and search methods for the Cochrane Airways Group Specialised Register
(CAGR)
Electronic searches: core databases
Database Frequency of search
CENTRAL Monthly
MEDLINE (Ovid) Weekly
EMBASE (Ovid) Weekly
PsycINFO (Ovid) Monthly
CINAHL (EBSCO) Monthly
AMED (EBSCO) Monthly
Handsearches: core respiratory conference abstracts
Conference Years searched
AmericanAcademyofAllergy, Asthma and Immunology (AAAAI) 2001 onwards
American Thoracic Society (ATS) 2001 onwards
Asia Pacific Society of Respirology (APSR) 2004 onwards
British Thoracic Society Winter Meeting (BTS) 2000 onwards
Chest Meeting 2003 onwards
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(Continued)
European Respiratory Society (ERS) 1992, 1994, 2000 onwards
International PrimaryCareRespiratoryGroupCongress (IPCRG) 2002 onwards
Thoracic Society of Australia and New Zealand (TSANZ) 1999 onwards
MEDLINE search strategy used to identify trials for the CAGR
Asthma search
1. exp Asthma/
2. asthma$.mp.
3. (antiasthma$ or anti-asthma$).mp.
4. Respiratory Sounds/
5. wheez$.mp.
6. Bronchial Spasm/
7. bronchospas$.mp.
8. (bronch$ adj3 spasm$).mp.
9. bronchoconstrict$.mp.
10. exp Bronchoconstriction/
11. (bronch$ adj3 constrict$).mp.
12. Bronchial Hyperreactivity/
13. Respiratory Hypersensitivity/
14. ((bronchial$ or respiratory or airway$ or lung$) adj3 (hypersensitiv$ or hyperreactiv$ or allerg$ or insufficiency)).mp.
15. ((dust or mite$) adj3 (allerg$ or hypersensitiv$)).mp.
16. or/1-15
Filter to identify RCTs
1. exp “clinical trial [publication type]”/
2. (randomised or randomised).ab,ti.
3. placebo.ab,ti.
4. dt.fs.
5. randomly.ab,ti.
6. trial.ab,ti.
7. groups.ab,ti.
8. or/1-7
9. Animals/
10. Humans/
11. 9 not (9 and 10)
12. 8 not 11
The MEDLINE strategy and RCT filter are adapted to identify trials in other electronic databases.
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Appendix 2. Search strategy to identify relevant trials from the CAGR
#1 AST:MISC1
#2 MeSH DESCRIPTOR Asthma Explode All
#3 asthma*:ti,ab
#4 #1 or #2 or #3
#5 MeSH DESCRIPTOR Telemedicine Explode All
#6 telehealth* or tele-health*
#7 telemedicine* or tele-medicine*
#8 (internet* or computer* or web*):ti,ab,kw
#9 interactive* or telecommunication*
#10 (telephone or phone or SMS):ti,ab,kw
#11 tele-monitor* or telemonitor*
#12 telemanagement or tele-management
#13 teleconsultation or tele-consultation
#14 telecare* or tele-care*
#15 telematic*
#16 telepharmacy or tele-pharmacy
#17 telenurs* or tele-nurs*
#18 (video or email or e-mail):ti,ab,kw
#19 remote NEXT consult*
#20 wireless or bluetooth
#21 tele-homecare or telehomecare
#22 “remote care”
#23 tele-support or telesupport
#24 mobile NEXT health*
#25 “computer mediated therapy”
#26 ehealth or e-health
#27 mhealth or m-health
#28 #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 or #16 or #17 or #18 or #19 or #20 or #21 or #22 or #23
or #24 or #25 or #26 or #27
#29 #4 and #28
#30 (#29) AND (INREGISTER)
[Note: in search line #1, MISC1 denotes the field in which the reference has been coded for condition, in this case, asthma]
C O N T R I B U T I O N S O F A U T H O R S
Kayleigh Kew: background, methods, data extraction, risk of bias assessment, analysis, interpretation, results write-up and discussion.
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
We chose to assess performance bias separately for objective and subjective outcomes. We added two exacerbation outcomes (those
requiring ED visit and those requiring hospital admission) because the definition pre-defined in the protocol (those requiring oral
steroids) did not always match how exacerbations were categorised in the included studies.
We could not interpret the planned subgroup analysis conducted to assess types of technology because the number of different
technologies was nearly as large as the number of included studies.
We did not conduct a sensitivity analysis upon removing studies at high risk of detection bias because we judged too few studies to be
at low risk of bias contributing to outcomes, and because high-risk studies contributed only to the exacerbations outcomes, which are
unlikely to have been affected by this type of bias.
We changed the title of the review from “Asthmamonitoring with remote feedback from a health professional” to “Home telemonitoring
and remote feedback between clinic visits for people with asthma”, following comments from the managing editor and the contact
editor to better describe the intervention under study in line with the published literature.We carried this change through the objectives
and the rest of the review for consistency.
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